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Summary 
 
This thesis is concerned with understanding the challenges faced by individuals living 
with Parkinson‟s disease. The first section comprises a literature review of 26 studies 
examining the predictive relationship between patients‟ symptoms and the level of 
burden reported by caregivers. Analysis of results suggests that whilst patient‟s motor, 
psychiatric and cognitive symptoms are associated with caregiver burden, there is less 
evidence of a direct predictive relationship. A critique of studies‟ methodologies 
highlights inconsistent measurement of caregiver burden and participant recruitment 
strategies that question the ecological validity of results. Clinical implications and 
directions for future research are addressed. The second section presents a qualitative 
study examining patient and caregiver perceptions of a neurosurgical procedure (deep 
brain stimulation) which aims to alleviate Parkinsonian motor symptoms. Through 
semi-structured interviews, this longitudinal study explores 8 patients‟ and 6 respective 
caregivers‟ expectations of surgery and their subsequent evaluations of its impact. 
Using Template Analysis, the study investigates whether participants‟ evaluations of 
surgery overlap with themes deemed salient prior to surgery, and whether patients and 
carers differ in their accounts. Findings suggest some consistency in pre- and post-
surgical discussions, with change in motor symptoms and quality of life deemed 
important. However, unanticipated difficulties with fluctuating symptom change and 
side effects impacted on satisfaction. Participants also evaluated the manner in which 
treatment was delivered. Patients and caregivers did not differ substantially in the 
themes discussed. Clinical implications of these findings are discussed as well as a 
critique of the study‟s methodology, with directions for future research proposed. 
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The Role of Motor, Psychiatric and Cognitive 
Symptoms in Predicting Caregiver Burden in 
Parkinson’s Disease: 
 
A Review of the Literature
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Abstract 
 
Parkinson‟s disease is characterised by not only motor impairments, but also cognitive 
and psychiatric disturbance. High levels of caregiver burden (CB) have been found in 
those providing informal support for sufferers, and researchers have examined the 
relationship between patient symptoms and CB. The aim of this literature review was to 
examine the quality of this research and assess the impact of the different components 
of the Parkinsonian symptom profile on CB. A systematic search of databases 
(PsycINFO, Web of Science, OVID Medline, British Nursing Index, CINAHL) 
revealed 26 studies of relevance. Analysis of study findings indicated that whilst motor, 
psychiatric, and cognitive impairments were associated with CB, the extent to which 
these symptoms independently predicted CB after controlling for covariates was 
limited. In many cases, level of patient disability was found to be a better predictor and 
was sometimes found to mediate the relationship between symptoms and CB. The only 
symptom that appeared to independently predict CB was the presence of psychosis. The 
comparison of results across studies is limited by heterogeneous use of conceptually 
varied burden measures. Biases in sampling strategies may mean that results lack 
ecological validity. Additional methodological weaknesses are addressed, and clinical 
implications and directions for future research discussed. 
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Introduction 
 
Informal caregiving is “the act of providing assistance to an individual with whom the 
caregiver has a personal relationship” (Kasuya et al, 2000, p.119). In the UK almost six 
million people provide unpaid healthcare assistance to others (Buckner & Yeandle, 
2007). Yet the provision of informal support can have significant consequences for 
caregivers. The term „caregiver burden‟ (CB) refers to the impact of caregiving on the 
carer‟s ability to meet their own basic needs (Braithwaite, 1996). It is commonly seen as 
a multidimensional concept involving the impact on caregivers‟ physical and emotional 
health, social functioning, and financial well-being (Zarit, 1980; 1986). 
 
Parkinson‟s disease (PD) is a chronic neurodegenerative movement disorder, primarily 
characterised by three cardinal motor symptoms: bradykinesia (i.e. slowed movement), 
ridigity, and resting tremor. Additional axial symptoms include postural instability and 
gait disturbance. Whilst medication can reduce the severity of motor symptoms, its 
effectiveness diminishes over time. In addition, its side effects include periods of 
dyskinesia (uncontrollable movements) which can fluctuate unpredictably to states of 
akinesia (loss of movement). PD is also associated with significant psychiatric and 
cognitive disturbance. An estimated 30-40% of sufferers present with clinical 
depression (Dooneief et al, 1992) and a similar percentage present with anxiety 
(Aarsland et al, 2009). Around 15-25% develop symptoms of psychosis, and up to 50% 
experience benign hallucinations (Aarsland et al, 1999; Hanagasi & Emre, 2005). The 
neurological basis of the disorder results in cognitive sequelae varying from relatively 
subtle impairments in memory retrieval, executive functioning, and visuomotor 
construction (Cooper et al, 1991; Taylor & Saint-Cyr, 1995), through to Parkinson‟s 
Disease Dementia which involves severe impairment in multiple cognitive modalities 
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and is akin to a dysexecutive syndrome (Marder & Jacobs, 2008). These non-motor 
symptoms often present from the earliest stages of the illness, suggesting that they are 
as central to the Parkinsonian symptom profile as more traditional conceptualisations 
around motor impairment. 
 
Over a third of PD sufferers receive support from an informal caregiver, with this 
number increasing as the disease progresses (Whetten-Goldstein, 1997). Research has 
accumulated demonstrating the impact on PD caregivers. Around 40% feel their health 
has suffered through caregiving (Schrag et al, 2006). Levels of emotional distress are 
higher than in other caregiver groups (Parrish et al, 2003) and consistently higher than 
the general population (Dura et al, 1990; O‟Reilly et al, 1996). The financial burden of 
PD results largely from the impact of lost earnings, both in the sufferer and the 
caregiver. A third of working age PD caregivers take early retirement or are on sick 
leave to meet the sufferer‟s needs (Lökk, 2008), with lost earnings estimated to be in the 
region of $12000 per year (Whetten-Goldstein et al, 1997). Socially, PD carers tend to 
have smaller social networks and a more restricted range of social contacts (Miller et al, 
1996). Most feel their social life has suffered through caregiving whilst 25% report a 
negative impact on their relationships with other family members (Schrag et al, 2006). 
 
This literature review is concerned with evaluating those studies that have examined the 
impact of PD symptoms (motor, psychiatric, and cognitive) on CB. The past 15 years 
has seen a steady growth of this literature base, yet to date there has been no attempt to 
review these findings. Our understanding of this area is important for a number of 
reasons. Firstly, understanding the predictors of CB allows services to direct limited 
funding towards areas where caregivers require assistance. Seventy percent of PD 
caregivers report requiring additional support (Parrish et al, 2003) and the NHS is 
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pledged to support caregivers of patients with long-term neurological conditions 
(Department of Health, 2005). Enabling caregivers to continue in their role reduces the 
likelihood of nursing home placements for the patient, which in turn has been linked to 
better health outcomes (Zarit et al, 1986). 
 
Secondly, understanding how symptoms affect CB potentially increases our 
understanding of how various PD treatments will affect caregivers. Current treatments 
have a differential impact across the Parkinsonian symptom profile. Levodopa 
medication, whilst effective in reducing the severity of some motor symptoms, can lead 
to additional motor impairments and neuropsychiatric symptoms (Molho, 2008). 
Neurosurgical treatments for PD, specifically deep brain stimulation of the subthalamic 
nucleus (STN-DBS), can improve levodopa-responsive motor symptoms and reduce 
medication use and dyskinetic side-effects (Limousin & Martinez-Torres, 2008). Yet it 
has little impact on motor symptoms unresponsive to levodopa, cognition and mood, 
with some studies showing exacerbation of cognitive and emotional impairments 
following surgery (Berney et al, 2002; Temel et al, 2006). Interestingly a recent study 
found the majority of caregivers to be disappointed with the results of STN-DBS 
(Schüpbach et al, 2006). It could therefore be proposed that non-targeted symptoms 
place a more significant strain on the caregiver. As Carter et al (2008) highlight: “before 
the impact of new PD medical and surgical therapies on caregivers can be evaluated, we 
must first understand how much variation in caregiver strain and depression is actually 
explained by symptoms of the disease” (p. 1211).  
 
 
 
 
6 
 
This literature review aims to address the following: 
 
1. The role of patients‟ motor, psychiatric and cognitive symptoms in predicting 
caregiver burden 
2. The most significant predictors of caregiver burden 
 
In order to address these aims effectively, this paper will first outline limitations in the 
studies‟ designs relating to participant recruitment strategies, the measurement of CB, 
and a reliance on cross-sectional methodology. This is necessary to understand 
subsequent findings. 
 
Search Method 
 
Relevant studies were retrieved through systematic searches (Appendix 3) in the 
databases of PsycINFO (1806 – February 2010), Web of Science (1900 – February 
2010), OVID Medline (1950 – February 2010), British Nursing Index (1985 – February 
2010) and CINAHL – Cumulative Index to Nursing and Allied Health Literature (1982 
– February 2010). The key term PARKINSON‟S DISEASE was entered and paired 
with each of the following key terms: 
 
* CAREGIVER BURDEN 
* CAREGIVER DISTRESS 
* CAREGIVER STRAIN 
* CAREGIVING 
* CAREGIVER STRESS 
* CAREGIVER QUALITY OF LIFE 
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* CAREGIVER WELL-BEING 
 
Examination of the titles and abstracts of resulting papers took place. Only papers 
published in English and in peer reviewed journals were included. Papers were required 
to include a detailed description of their methodology and results, thus allowing a 
critique of their findings. Short articles and abstracts from conference presentations 
were therefore excluded. Since this review was concerned with idiopathic PD, papers 
including other forms of Parkinsonism were excluded. Papers were required to examine 
at least one aspect of the care-recipient‟s motor, cognitive, or psychiatric symptom 
profile and assess its impact on caregiver burden. Studies had to provide some 
measurement of the negative impact of caregiving. Twenty-six studies met these 
inclusion criteria. Table 1 provides details of these studies including the areas of patient 
symptomatology examined. 
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Table 1 – Patient Symptomatology Examined in Reviewed Papers 
 
Study 
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Caap-Ahlgren & Dehlin (2002) *    *      
Carter et al (1998) *          
Carter et al (2008)     *     * 
D’Amelio et al (2009) * *   *   *   
Fernandez et al (2001) * *   *  * *   
9 
 
Goldsworthy & Knowles (2008)        *   
Happe & Berger (2002)  *   *      
Kim et al (2007) *          
Lyons et al (2009) *          
Marsh et al (2004)  *   *  * *   
Martínez-Martín et al (2003) * *         
Martínez-Martín et al (2005) * * *  * *  *   
Martínez-Martín et al (2007) *    *      
Martínez-Martín et al (2008) * * *  * *  *   
Meara et al (1999)  *   *   *   
Miller et al (1996) * *   * *    * 
Parrish et al (2003)     *      
Reading et al (2001)       * *   
Schrag et al (2006) *   * *  *    
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Speer et al (1993)     *      
Stella et al (2009) *    *    *  
Takeda et al (2005) *   * *   *   
Tanji et al (2008) *   *    *   
Thommessen et al (2002)     *   *   
Wallhagen & Brod (1997)  *         
Washio et al (2002)         *  
 
* Areas that studies have addressed 
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Results 
 
1.0 BIASES IN PARTICIPANT RECRUITMENT STRATEGIES 
 
Prior to examining the relationship between symptoms and CB, it is necessary to 
consider the inclusion/exclusion criteria for participation in the reviewed studies. As 
will be outlined, such recruitment biases may result in samples unrepresentative of the 
wider PD caregiver/receiver population. In addition, inconsistent recruitment criteria for 
caregivers means comparisons of results may be confounded since extent of caregiving 
may vary between samples. 
 
A number of studies excluded patients at the extreme ends of the age spectrum. 
Younger patients were excluded to minimise the inclusion of atypical forms of PD 
(Martinez-Martin et al, 2005; 2008; Wallhagen & Brod, 1997), whilst older patients 
were excluded to minimise the risk of additional health problems confounding the 
results (Martinez-Martin et al, 2008; Miller et al, 1996). Related to this, some studies 
excluded patients with comorbid dementia (Happe & Berger, 2002; Meara et al, 1999; 
Reading et al, 2001; Wallhagen & Brod, 1997), whilst others were less specific and 
excluded patients with “comorbid difficulties seen to impair assessment” (Martinez-
Martin et al, 2003; 2005; 2008). Whilst these exclusion criteria give the reader more 
confidence that any effect on CB is mediated by PD symptoms, it reduces the ecological 
validity of the results since many sufferers do experience additional health problems and 
global cognitive decline. It is also likely to limit the participation of older sufferers who 
are more likely to experience such comorbidities (Hughes et al, 2000). Exclusion of 
older sufferers is also likely to reduce the number of participants with more advanced 
PD symptoms. 
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In terms of inclusion/exclusion criteria for caregivers, nine studies stipulated that this 
must be the patient‟s spouse (Carter et al, 1998; 2008; D‟Amelio et al, 2009; Fernandez 
et al, 2001; Happe & Berger, 2002; Lyons et al, 2009; Speer et al, 1993; Thommessen et 
al, 2002; Wallhagen & Brod, 1997). A further seven stated it must be someone living 
with the patient, thereby biasing recruitment towards spouses (Martinez-Martin et al, 
2005; 2007; 2008; Meara et al, 1999; Miller et al, 1996; Reading et al, 2001; Tanji et al, 
2008). Results may therefore be less reflective of other caregiver/receiver relationships. 
It also means that PD patients without spouses are automatically excluded from studies. 
A third difficulty is that studies that recruited spouses assumed that these individuals 
were the primary caregivers, with little attempt to examine whether they identified with 
the „caregiver‟ role or measure the amount of care provided. Only four studies provided 
a working definition of „caregiver‟ which stipulated that this person must provide direct 
care and be directly affected by care-recipient health problems (Caap-Ahlgren & 
Dehlin, 2002; Martinez-Martin et al, 2005; 2007; 2008). Therefore most studies may 
have included some caregivers who were either not the primary caregivers or provided a 
limited amount of care and thus might be inappropriate in relation to examining the 
impact of care-recipient symptoms. 
 
2.0 THE MEASUREMENT OF CAREGIVER BURDEN 
 
In order to understand the relationship between patient symptoms and caregiver burden, 
it is important to consider the aspects of burden that have been examined. It is also 
important to examine the integrity of the measures used to assess this dimension. Table 
2 displays the various measures used by studies.  
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Table 2 – Measures of Caregiver Burden 
 
Study No. of 
participants 
(patient/caregiver 
dyads) 
Generic 
burden 
measure 
Emotional well-
being measure 
Social well-being 
measure 
Financial well-
being measure 
Health 
functioning 
measure 
 
Caap-Ahlgren & Dehlin 
(2002) 
65 CBS GDS-15    
Carter et al (1998) 219 FCI CES-D    
Carter et al (2008) 380 FCI     
D’Amelio et al (2009) 40 CBI     
Fernandez et al (2001) 45  HAM-D    
Goldsworthy & Knowles 136 1) CBI Rosenberg Self- RAS   
14 
 
(2008) 2) SQLC Esteem Scale 
Happe & Berger (2002) 101  CES-D   Sleep problems 
Kim et al (2007) 68 Montgomery 
Burden Scale 
    
Lyons et al (2009) 255 FCI     
Marsh et al (2004) 50 ZBI     
Martínez-Martín et al 
(2003) 
60 SQLC     
Martínez-Martín et al 
(2005) 
62 SQLC     
Martínez-Martín et al 
(2007) 
80 ZBI HADS   1) SF-36 
2) EuroQoL 
Martínez-Martín et al 286 ZBI HADS   EuroQoL 
15 
 
(2008) 
Meara et al (1999) 79  GDS-15    
Miller et al (1996) 54 MSS 1) GHQ 
2) BDI 
3) GDS-15 
   
Parrish et al (2003) 324  1) CES-D 
2) Reports of distress 
for various patient 
symptoms 
   
Reading et al (2001) 12  NPI – distress scale    
Schrag et al (2006) 91 1) CBI 
2) SQLC 
BDI    
Speer et al (1993) 26 CCI GDS-15 ISEL  1)Duke-North 
16 
 
2) Health & 
Daily Living 
Form 
Stella et al (2009) 50  NPI – distress scale    
Takeda et al (2005) 14  Zung Self-Rating 
Depression Scale 
Questions regarding: 
i) impact on social 
life 
ii) No. of hours with 
care-recipient 
iii) No. of hours 
providing care 
Expenses from: 
i) Transport 
ii) Medical 
devices 
iii) Care devices 
iv) Social 
services 
Presence of 
fatigue 
Tanji et al (2008) 96   Mutuality Scale   
Thommessen et al (2002) 58 RSS     
17 
 
Wallhagen & Brod (1997) 45 ZBI MOS    
Washio et al (2002) 70  CES-D    
 
 
Beck Depression Inventory (BDI); Caregiver Burden Inventory (CBI); Caregiver Burden Scale (CBS); Centre for Epidemiological Studies Depression 
Scale (CES-D); Cost of Care Index (CCI); Family Caregiving Inventory (FCI); General Health Questionnaire (GHQ); Geriatric Depression Scale 
(GDS); Hamilton Depression Scale (HAM-D); Hospital Anxiety and Depression Scale (HADS); Interpersonal Support Evaluation List (ISEL); Machin 
Strain Scale (MSS); Medical Outcomes Study Mental Health Index (MOS); Neuropsychiatric Inventory (NPI); Relationship Assessment Scale (RAS); 
Relatives‟ Stress Scale (RSS); Scale of Quality of Life of Caregivers (SQLC); Short-Form Health Survey – 36 item (SF-36); Zarit Burden Inventory 
(ZBI)
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The examination of the comprehensiveness of the studies‟ CB measurement will 
consider how they have addressed Zarit‟s (1980; 1986) conceptualisation of burden: 
social functioning, physical health, emotional well-being, and financial well-being. 
 
2.1 Generic Burden Measures 
 
Those questionnaires termed „generic burden measures‟ refer to tools specifically 
developed for measuring CB and are multidimensional in construct. Their perceived 
strength is that, having been developed with caregiver samples, they should address 
issues salient to CB. However, as Chou et al (2003) note, the majority have been 
developed with dementia caregivers and have questionable validity with other caregiver 
samples. None have been examined for their discriminant validity or test-retest 
reliability in PD. Across the 17 reviewed studies that utilised such measures, nine 
different questionnaires were used. Each scale conceptualises burden slightly 
differently, making comparisons of results between studies difficult. The two scales 
used most commonly were the Zarit Burden Inventory (ZBI; Zarit et al, 1980) and the 
Scale of Quality of Life of Caregivers (SQLC; Glozman et al, 1998). Whilst there is 
some overlapping conceptualisation of burden between these scales, the ZBI includes 
items on the financial and health-related costs of care which is neglected by the SQLC. 
In contrast the SQLC examines how caregiving interferes with occupational demands; 
an area neglected by the ZBI. Varied conceptualisation of burden is found across all 
burden measures in the reviewed studies. Furthermore, whilst there are overlapping 
dimensions in these measures, some scales do not permit summary scores for individual 
dimensions or authors have not taken advantage of this and instead have presented the 
composite score. As well as creating difficulties with between-study comparisons, the 
failure to report subscale scores means that the reader is unable to determine which 
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aspects of burden are most affected by various PD symptoms. Only four studies 
examined these individual subscales (Carter et al, 1998; 2008; Lyons et al, 2009; Kim et 
al, 2007). 
 
2.2 Measures of specific components of burden 
 
A means through which to overcome the difficulties described above is to use 
questionnaires measuring a single construct. Eighteen studies used such measures. The 
most common dimension under assessment was caregiver mental well-being. This was 
assessed through psychometric measures of depression, anxiety, self-esteem, 
stress/distress, and general mental health, all of which were recognised measures with 
satisfactory psychometric properties. Far fewer studies measured other components of 
burden. In terms of social well-being, two studies used psychometric measures 
examining quality of the caregiver/recipient relationship (Goldworthy et al, 2008; Tanji 
et al, 2008). Speer et al (1993) measured ability to undertake social pursuits and 
satisfaction from this. Another did not use a psychometric measure and instead asked 
directly about the impact of caregiving on the caregiver‟s social life (Takeda et al, 
2005). Five studies examined impact on caregiver physical health.  Three examined 
health-related quality of life (Martinez-Martin et al, 2007; 2008; Speer et al, 1993), 
whilst two looked at specific symptoms (Happe & Berger, 2002; Takeda et al, 2005). 
Only one study addressed the financial consequences of caregiving (Takeda et al, 2005), 
but made no attempt to examine lost earnings, even though this is the greatest financial 
burden in PD (Whetten-Goldstein et al, 1997). 
 
Single construct measures therefore allow greater clarity in understanding which aspects 
of burden are affected by patient symptoms. They also increase the feasibility of 
20 
 
comparing results between studies. However, with the exception of caregiver emotional 
well-being, only a few studies have examined other specific burden dimensions. 
Furthermore, since these measures have not been developed with caregiver samples, 
they may not actually address the issues most pertinent to caregivers. 
 
3.0 RELIANCE ON CROSS-SECTIONAL METHODOLOGY 
 
Of the 26 studies included in the review, 24 adopted a cross-sectional design whereby 
the relationship between patient symptoms and CB was measured at a single point in 
time. In the context of this review, the limitation of this approach is that such studies do 
not permit an examination of how patients‟ symptoms are likely to predict CB over 
time. Only two studies used a longitudinal design to approach the research question, 
whereby the impact of changes in patient symptoms on CB was examined (Lyons et al, 
2009; Reading et al, 2001). However, the study by Reading et al (2001) was limited by 
a reliance on descriptive statistical analysis regarding the relationship between patient 
symptoms and CB. 
 
4.0 THE IMPACT OF MOTOR SYMPTOMS 
 
4.1 Disease Stage 
 
Parkinson‟s disease motor symptoms are often categorised by disease stage through use 
of the Hoehn & Yahr (H&Y) assessment tool. It differentiates stages of PD by the 
presence/absence of bilateral motor impairment and the presence/absence of postural 
instability. Sufferers are classified into one of five stages, with higher stages indicating 
greater symptom severity. 
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Fifteen studies examined whether H&Y stage was associated with CB (see Table 1). 
Three used between-groups methodology whereby level of CB was compared across 
H&Y stages (Carter et al, 1998; Kim et al, 2007; Martinez-Martin et al, 2008), with the 
remainder of studies examining the correlation between H&Y stage and level of CB. 
Higher H&Y stages were associated with higher scores on generic burden measures, 
including the Caregiver Burden Inventory (Caap-Ahlgren & Dehlin, 2002; D‟Amelio et 
al, 2009; Schrag et al, 2006), Family Caregiving Inventory (Carter et al, 1998; Lyons et 
al, 2009), SQLC (Martinez-Martin et al, 2003; 2005; Schrag et al, 2006), ZBI 
(Martinez-Martin et al, 2007; 2008), and the Machin Strain Scale (Miller et al, 1996). 
Kim et al (2007) found that higher H&Y stages were associated with increased scores 
on a scale assessing the objective/tangible costs of care, but did not impact on subjective 
burden (i.e. the emotional impact of caring). Related to this, most studies found no 
relationship between H&Y stage and caregiver mood (Fernandez et al, 2001; Miller et 
al, 1996; Stella et al, 2009) or at best a weak association (Martinez-Martin et al, 2008; 
Schrag et al, 2006). The only study to examine its impact on caregiver health-related 
quality of life found a weak correlation (Martinez-Martin et al, 2008). It did not 
correlate with the quality of the caregiver/receiver relationship (Tanji et al, 2008) or 
financial burden (Takeda et al, 2005), although the latter study had a very small sample 
size (n=14). 
 
The above studies suggest that higher disease stage is associated with higher scores on 
generic burden measures, with some evidence that it affects caregiver health related 
quality of life. However, a critique of the H&Y is that it does not provide a „pure‟ 
measure of motor symptom severity as disease stage is partly determined by patient 
functionality, i.e. ability to complete daily living tasks (Goetz et al, 2004). Therefore the 
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above results may in fact be associated with patient functionality rather than motor 
symptom severity per se. Five of the above studies examined whether H&Y 
independently predicted CB by entering it into a regression analysis alongside other 
variables found to correlate with CB. The two studies that controlled for the effect of 
patient functionality found H&Y no longer independently predicted CB (Martinez-
Martin et al, 2005; Miller et al, 1996). Those studies that did not control for this variable 
did find an independent effect of H&Y stage (Caap-Ahlgren & Dehlin, 2002; D‟Amelio 
et al, 2009; Lyons et al, 2009). Therefore, patient functionality appears to be a better 
predictor of CB and could possibly mediate the relationship between H&Y and CB, 
although this was not examined directly. 
 
4.2 Extent of Motor Symptoms 
 
An alternative approach to measuring motor symptom severity has involved using 
scales which sum the severity scores of each of the PD motor symptoms. The Unified 
Parkinson‟s Disease Rating Scale – motor subscale (UPDRS-motor) is the best known 
of these clinician-rated measures and was used in five studies. Scores on this measure 
correlated with all burden measures, which included caregiver distress (D‟Amelio et al, 
2009), depression (Fernandez et al, 2001), sleep disturbance (Happe & Berger, 2002), 
the ZBI (Marsh et al, 2004) and quality of life (Martinez-Martin et al, 2003). No studies 
examined its relationship with physical health, social or financial well-being of carers. 
A number of these studies examined the independence of the relationship when other 
variables were entered into a regression analysis. It continued to predict caregiver sleep 
disturbance (Happe & Berger, 2002). However the relationship with caregiver distress 
was no longer significant, and instead patient mental health was the main predictor 
(D‟Amelio et al, 2009). Of note, caregiver distress was measured by the 
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Neuropsychiatric Inventory (NPI) distress scale which specifically examines carer 
distress caused by patient mental health symptoms. Therefore it is not surprising that 
psychiatric symptoms were a better predictor than UPDRS-motor. Carer depression was 
no longer predicted by UPDRS-motor (Fernandez et al, 2001). Patient functionality was 
found to be a better predictor of carer quality of life than UPDRS-motor (Marsh et al, 
2004).   
 
Five studies used alternative motor severity scales. Two studies (Meara et al, 1999; 
Miller et al, 1996) used the Webster scale. Neither found a significant correlation with 
caregiver mood, nor were depressed caregivers more likely to be caring for patients with 
higher Webster scores. Miller et al (1996) found that motor severity correlated with a 
measure of objective burden (Machin Strain Scale), although once other variables were 
entered into a regression analysis this relationship no longer remained significant; 
patient functionality instead emerged as the strongest predictor of carer strain. The lack 
of a relationship between motor symptoms (as measured by the Webster scale) and 
caregiver depression stands in contrast to the results reported by Fernandez et al (2001) 
using the UPDRS-motor. Of note, the Webster scale has been criticised for being 
conceptually unclear since it combines both motor symptoms and functional impairment 
(Ramaker et al, 2002). There is also little published evidence for its validity and 
reliability; with some studies finding poor inter-rater reliability (Geminiani et al, 1991). 
In contrast, the UPDRS-motor is found to have stronger clinimetric properties (Ramaker 
et al, 2002). This may offer some explanation for this inconsistency. 
 
Martinez-Martin et al (2005) found that motor symptom severity, as measured by the 
Intermediate Scale for Assessment of Parkinson‟s Disease (ISAPD), correlated with 
reduced caregiver quality of life. Unfortunately the authors did not report whether this 
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remained significant following a regression analysis alongside other covariates, 
although they noted it was not a major determinant of burden. Again patient functional 
ability was the most significant predictor. Martinez-Martin et al (2008) used the Scales 
for Outcomes in Parkinson‟s Disease (SCOPA) to assess motor symptom severity. This 
correlated with caregiver mood, quality of life, and the ZBI. However, following factor 
analysis it was not identified as a significant determinant of burden.  
 
Only one study found a relationship between motor symptom severity and caregiver 
burden (specifically depression) that remained significant after other covariates were 
included in a regression analysis (Wallhagen & Brod, 1997). However this study 
differed from those above in that instead of using an objective symptom measure, 
participants were asked to rate perceived control over motor symptoms. Therefore this 
study is examining a different concept to the above studies. Since lack of perceived 
control is a dimension often linked to psychological distress (Seligman, 1974) it is 
perhaps less surprising that this study found an association with burden. It does however 
raise an interesting consideration that it is not so much the extent of motor symptom 
severity but its perceived controllability which may influence burden. 
 
4.3 Medication induced motor impairments 
 
Levodopa can result in significant motor impairments such as dyskinetic movement 
which can unpredictably fluctuate to periods of akinesia. None of the scales outlined 
above measure this motor disturbance. Martinez-Martin et al (2005) measured this with 
the ISAPD complication subscale. This correlated with reduced caregiver quality of life. 
Unfortunately the authors did not report whether this relationship remained significant 
after it was entered into a regression analysis alongside other covariates, although they 
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noted that it was not a major determinant of burden. A similar difficulty is found in 
interpreting Martinez-Martin et al‟s (2008) study. This study found that motor 
complications, as measured by the SCOPA, were associated with greater caregiver 
depression, anxiety and ZBI scores. However, it was grouped with disease duration and 
disability during factor analysis and as such its individual contribution remains unclear. 
 
4.4 Specific symptoms 
 
A difficulty with assessing the impact of motor symptoms through a cumulative score 
on a clinimetric measure is that it does not allow for the examination of whether specific 
symptoms are particularly challenging for caregivers. A number of studies have 
therefore examined the role of individual motor symptoms in contributing to burden. 
Tanji et al (2008) examined how scoring on each of the UPDRS items affected the 
quality of the caregiver/receiver relationship. Increases in the following symptoms 
correlated with poorer relationships: gait impairment, postural instability, and motor 
fluctuations. Only gait disturbance emerged as a significant predictor following 
inclusion in a regression analysis alongside other covariates, although postural 
instability was not examined due to its large intercorrelation with gait. Somewhat 
similar results were found by Schrag et al (2006) who used a group comparison 
approach to examine burden in caregivers whose care-recipients either did or did not 
have the motor impairment in question. The motor impairments consisted of falls, 
involuntary movements, and motor fluctuations. Only carers whose recipients 
experienced falls had higher Caregiver Burden Inventory scores and lower quality of 
life; no group differences were found on measures of mood. This study also asked 
patients to indicate the percentage of the day that they were in an akinetic state. This 
was found to correlate with all three measures of burden, although the relationship was 
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not explored through regression analysis. Finally, Takeda et al (2005) examined the 
relationship between burden and tremor, rigidity, akinesia, bradykinesia, posture, and 
gait. With the exception of tremor, these all correlated with at least one aspect of 
caregiver burden. However, the reliability of these results is questionable given the 
small sample size.  
 
5.0 THE IMPACT OF PSYCHIATRIC DISTURBANCE 
 
5.1 Patient Depression 
 
Patient depression was the most commonly examined aspect of patient mental health, 
addressed in 16 studies (see Table 1). Using a between-groups methodological design, 
Stella et al (2009) found higher rates of caregiver distress (as measured by the NPI) in 
those caring for a patient with a DSM-IV diagnosis of depression than in caregivers of 
non-depressed patients. However, as noted in Section 4.2, the NPI is biased toward 
finding higher caregiver distress in patients with mental health problems and is 
therefore a poor measure in this context. The remaining 15 studies used correlation to 
investigate the relationship between patient depression and CB. Patient depression was 
measured by a range of psychometric measures, with all measures found to have 
satisfactory psychometric properties for the measurement of depression in PD (Schrag 
et al, 2007). Patient depression consistently correlated with caregiver mood (Carter et al, 
2008; Fernandez et al, 2001; Happe & Berger, 2002; Martinez-Martin et al, 2008; 
Meara et al, 1999; Miller et al, 1996; Schrag et al, 2006; Speer et al, 1993). Only one 
study did not find that greater patient depression was associated with higher levels of 
caregiver mood disturbance (Takeda et al, 2005), although this study has a number of 
weaknesses of which its small sample size is the most significant. Three studies 
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examined whether depression continued to be associated with carer mood following 
entry of other covariates in a regression analysis (Carter et al, 2008; Fernandez et al, 
2001; Miller et al, 1996). Only one found the relationship remained (Miller et al, 1996), 
although this study included a large number of predictor variables in what was a 
relatively small sample. Yet Carter et al (2008), who found no predictive relationship, 
used a much larger sample (n=219) and so more confidence can be placed in their 
results. However the mean depression score for this PD sample was very low and so one 
might question whether a significant independent relationship would have been found if 
more patients had depression scores in the clinically significant range. 
 
Patient depression was also found to correlate with a number of generic burden 
measures, including the Caregiver Burden Inventory (Caap-Ahlgren & Dehlin, 2002; 
D‟Amelio et al, 2009 Schrag et al, 2006), Family Caregiving Inventory (Carter et al, 
2008), ZBI (Marsh et al, 2004; Martinez-Martin et al, 2007; 2008), Machin Strain Scale 
(Miller et al, 1996), SQLC (Martinez-Martin et al, 2005; Schrag et al, 2006) and the 
Relatives‟ Stress Scale (Thommessen et al, 2002). Only one generic burden measure 
(Cost of Care Index) was not found to correlate with patient depression (Speer et al, 
1993). After other covariates were included in a regression analysis, patient depression 
no longer independently predicted scores on the Caregiver Burden Inventory (Caap-
Ahlgren & Dehlin, 2002; D‟Amelio et al, 2009), ZBI (Marsh et al, 2004), and SQLC 
(Martinez-Martin et al, 2005). Most found patient functionality to be a better predictor. 
However the Family Caregiving Inventory (Carter et al, 2008), Machin Strain Scale 
(Miller et al, 1996) and Relatives‟ Stress Scale (Thommessen et al, 2002) continued to 
be predicted by patient depression, even after controlling for patient functionality. 
Given that each of these scales conceptualises burden slightly differently, it is possible 
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that there is some salient dimension inherent in all measures where findings remained 
significant. 
 
In relation to health-related quality of life, whilst one study found that it was correlated 
with patient depression (Martinez-Martin et al, 2008), another did not (Martinez-Martin 
et al, 2007). The results of the former study came from a much larger sample (289 
versus 80 caregiver/receiver dyads), hence more value can be attached to these findings. 
Patient depression was not related to caregiver physical health complaints (Speer et al, 
1993) or fatigue (Takeda et al, 2005). In terms of social burden, patient depression was 
associated with caregiver‟s decreased perceptions of social support (Speer et al, 1993), 
but not their level of social activity (Speer et al, 1993; Takeda et al, 2005). It was not 
found to be associated with financial burden (Takeda et al, 2005). 
 
5.2 Patient Anxiety 
 
Three studies investigated the correlation between patient anxiety and CB. Martinez-
Martin et al (2008) found higher scores on the anxiety subscale of the Hospital Anxiety 
and Depression Scale (HADS) correlated with worse caregiver emotional well-being 
and quality of life, and higher scores on the ZBI. Using the Hamilton Anxiety scale, 
Miller et al (1996) found that anxiety correlated with worse caregiver emotional well-
being and increased objective burden (as measured by the Machin Strain Scale). 
However after other covariates were included alongside patient anxiety in a regression 
analysis this relationship was no longer significant, with patient depression found to be 
a better predictor. Martinez-Martin et al (2005) found that higher scores on the HADS 
correlated with poorer quality of life in caregivers. Again this relationship no longer 
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remained significant when other covariates were included alongside patient anxiety in a 
regression analysis, with patient functionality found as a better predictor. 
 
The evidence therefore suggests that anxiety, whilst associated with caregiver burden, is 
not a significant independent predictor. Instead patient depression and degree of 
functional impairment are better predictors, although none of the studies examined 
whether these variables mediated the relationship between patient anxiety and burden. 
Of note, whilst the above anxiety measures are routinely used in mental health settings, 
a recent review highlighted weaknesses in their application to PD samples (Leentjens et 
al, 2008). Specifically, the HADS is poor at discriminating between anxiety and 
depression, and the Hamilton scale has not been validated with this population. This is a 
significant concern given that PD symptoms can overlap with symptoms of anxiety (e.g. 
restlessness, sweating, muscle tension). Finally, regression studies had insufficient 
participants for the number of predictor variables included in their analyses (Tabachnick 
& Fidell, 2006). 
 
5.3 Psychotic symptoms 
 
Four studies investigated the impact of psychotic symptoms on caregiver burden. 
Schrag et al (2006) found that those individuals caring for a patient with hallucinations 
had higher scores on the Caregiver Burden Inventory and lower quality of life than 
carers of patients without such disturbance. However, caring for someone with 
hallucinations did not impact on caregiver mood (Schrag et al, 2006; Fernandez et al, 
2001). Reading et al (2001) found that improvements in patient psychotic symptoms 
were accompanied by reduced caregiver distress, as measured by the NPI distress scale. 
However the authors did not actually examine the degree of correlation between these 
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variables. Furthermore this study had a very small sample size (n=12) and, as discussed 
in previous sections, the use of the NPI scale is biased towards recording reduced 
burden when psychiatric symptoms reduce. 
 
A weakness of the above studies is that none attempt to control for covariates. For 
example, hallucinations are common in PD patients with dementia (Stella et al, 2009) 
and it is possible that cognitive decline rather than hallucinations per se are the salient 
predictor of this relationship. Only one study attempted to control for covariates through 
regression analyses (Marsh et al, 2004). They found that the presence of psychotic 
symptoms independently predicted caregiver burden (as measured by the ZBI) when 
controlling for the effects of patient cognitive status, mood, motor symptoms, and 
functionality. The analysis is however weakened by the poor predictor variable to 
participant ratio. 
 
These studies therefore suggest that the presence of psychosis has little impact on 
caregiver mood, although it is at least associated with burden more generally as well as 
poorer quality of life. Unfortunately, none of the above studies differentiated between 
benign and florid hallucinations. The former are more common in PD whilst the latter 
are more likely to be associated with disruptive behaviour. One might therefore expect 
them to have a differential effect on burden. Furthermore, none of the studies examined 
the frequency of hallucinations and whether this mediated any relationship with burden. 
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6.0 THE IMPACT OF COGNITIVE IMPAIRMENT 
 
6.1 Global Cognitive Functioning 
 
The most common approach to assessing the impact of care-recipient cognitive 
functioning involved using global cognitive functioning measures commonly used to 
screen for dementia. Seven studies used the Mini-Mental State Examination (MMSE) 
which examines cognitive functioning along five dimensions: concentration and 
working memory, language and praxis, orientation, memory, and attention span. It 
correlated with a number of generic burden measures including the Caregiver Burden 
Inventory (D‟Amelio et al, 2009), the ZBI (Marsh et al, 2004) and the Relatives‟ Stress 
Scale (Thommessen et al, 2002). Only the latter finding remained significant once other 
covariates were added to a regression analysis, the relationship with the ZBI being 
better predicted by patient functionality, and the Caregiver Burden Inventory predicted 
by H&Y stage. As noted in Section 4.1, H&Y correlates with patient functionality and 
the above study did not control for this variable suggesting that this may be a more 
significant predictor. In terms of carer mental well-being, Fernandez et al (2001) found 
no significant difference in caregiver depression scores as a function of whether they 
were caring for a patient who scored either above or below the overall sample‟s average 
MMSE score. However, the average MMSE score was high suggesting that many of 
those patients included in the „impaired‟ group had only mild cognitive deficits. Takeda 
et al (2005) also found no correlation with carer mood, although this study had a very 
small sample size (n=14). Using a longitudinal design, Reading et al (2001) found that 
treatment of PD patients with an antipsychotic led to both improved cognition (as 
measured by the MMSE) and reduced caregiver distress. However, the authors did not 
directly examine the relationship between cognition and carer distress using inferential 
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statistical analysis. Furthermore, the sample size was small (n=12). In terms of caregiver 
social well-being, reduced MMSE scores were associated with a worse 
caregiver/receiver relationship (Tanji et al, 2008) and lifestyle restrictions (Takeda et al, 
2005). The latter study also found that cognitive impairment correlated with financial 
burden. 
 
Four studies used global cognitive assessments other than the MMSE. Goldworthy & 
Knowles (2008) found that the relationship between performance on the Mental Status 
Examination and burden (Caregiver Burden Inventory) was mediated by patient 
functionality and behavioural problems. Martinez-Martin et al (2005) also found a 
correlation between patient cognition (Pfeiffer‟s Short Portable Mental Status 
Questionnaire) and caregiver quality of life although, following entry of other covariates 
into a regression analysis, only patient functionality predicted burden. The only study to 
use a cognitive measure designed for PD samples (Scales for Outcome in Parkinson‟s 
disease – Cognition subscale) found that poorer cognition correlated with increased 
burden scores on the ZBI. This study benefits from having a large sample size (n=286), 
although unfortunately the authors did not conduct a regression analysis. All of the 
studies discussed above have examined patient cognition using brief cognitive measures 
and thus could be seen as insensitive to the subtle cognitive sequelae typically seen in 
PD. Meara et al (1999) instead examined patient cognition using the Cambridge 
Cognitive Examination (CAMCOG) which is over twice the length of the MMSE and 
measures similar cognitive modalities. This study found that cognition scores did not 
correlate with caregiver depression. However this study excluded participants who had 
CAMCOG scores suggestive of dementia and therefore at best can only claim that mild-
moderate cognitive impairment is not associated with caregiver depression. 
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In reviewing these studies as a whole, their major weakness relates to the use of 
cognitive measures which are inappropriate for examining the cognitive modalities and 
degree of impairment typically seen in PD. Measures tended to be brief and thus 
possibly insensitive to the subtle cognitive sequelae of PD. Mamikonyan et al (2009) 
found the MMSE to be poor at detecting cognitive impairment in PD, which they 
attributed to the MMSE‟s narrow focus on memory and language in addition to its high 
probability of ceiling effects. Similar criticisms around validity have been made 
regarding other measures, including the CAMCOG (Kulisevsky & Pagonabarraga, 
2009). In support of this, those studies which reported the sample‟s mean and standard 
deviation of scoring on these measures all showed limited cognitive impairment and 
small variations in scoring between participants. The only study to use a measure that 
was designed to assess the cognitive sequelae of PD was that of Martinez-Martin et al 
(2008).  
 
6.2 The Impact of Dementia 
 
Two studies used group comparison approaches to examine the link between severe 
cognitive impairment and CB. Washio et al (2002) found that depressed caregivers were 
no more likely to be caring for dementing PD sufferers than non-depressed caregivers. 
Stella et al (2009) grouped PD care-recipients by whether or not they had a diagnosis of 
dementia. In contrast to the preceding study, they found that caregivers of dementing 
patients showed higher levels of distress, as measured by the NPI distress scale. 
However, as stated previously, the NPI is limited to measuring distress caused by 
neuropsychiatric symptoms. Since PD dementia is associated with psychotic symptoms 
(Sanchez-Ramos et al, 1996) it is unsurprising that this study found higher ratings of 
caregiver distress. This group analysis approach is also problematic in so far as it does 
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not control for other variables that may also impact on burden. For example, in the 
above study care-recipients with dementia also had longer disease duration, worse 
motor symptoms, and higher rates of depression. 
 
6.3 Specific Cognitive Functions 
 
A criticism of most of the above studies is that they have examined the most severe 
form of cognitive impairment in PD (i.e. dementia) or have used instruments which may 
be insensitive to the specific forms of cognitive deterioration seen in PD. Two studies 
have instead focused on more specific forms of cognition. Carter et al (2008) assessed 
delayed recall in a verbal memory task in a large sample of 219 PD participants. Using 
regression analyses they found that this was an independent predictor of caregiver strain 
and depression. In contrast to these results, Miller et al (1996) found that patient‟s 
general intellectual functioning, delayed verbal recall memory, and spatial awareness 
were not correlated with burden, as conceptualised by caregiver depression and a 
measure of objective burden (Machin Strain Scale). The reasons behind these 
inconsistent findings are unclear since both found cognition to be impaired, both had 
similar predictor and dependent variables, and the composition of the sample was 
similar (spouse caregivers, similar age). Neither study measured whether caregivers 
were supported in their role or how much time they spent with the care-receiver and it is 
possible that this might mediate the impact of caring for a cognitively impaired patient. 
Given that Carter et al‟s (2008) study had a substantially larger sample size, this result 
has more credibility. 
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Discussion 
 
Overview of findings 
 
The reviewed studies indicate that patient symptoms are associated with burden to 
varying degrees. More advanced disease stage was associated with increased scores on 
generic burden measures, with care-recipient impairments on daily living tasks possibly 
mediating this relationship, although this was not directly examined. Disease stage did 
not substantially impact on caregiver mood. Few studies examined its impact on other 
aspects of burden. Composite measures of motor symptom severity (e.g. UPDRS) 
tended to correlate with generic burden measures, quality of life and caregiver mood, 
although patient functionality was a better independent predictor. Medication-induced 
motor impairments correlated with burden, although it is unclear whether they predict 
burden. Gait disturbance and postural instability associated with falls were found to be 
the most burdensome motor symptoms. 
 
Increased patient depression was typically associated with poorer caregiver mood and 
higher scores on generic burden measures. The evidence is less consistent in relation to 
caregiver physical and social well-being. It did not impact on financial burden. It is 
unclear whether patient depression predicts CB, or what variables might mediate this 
relationship. Higher patient anxiety was associated with reduced caregiver mood, 
quality of life, and increased scores on generic burden measures. Patient anxiety did not 
predict burden. The presence of psychotic symptoms was associated with increased 
scores on generic burden measures and reduced caregiver quality of life. It had no 
impact on caregiver mood. There was some evidence that it predicted burden. 
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Cognitive impairment tended to be measured using assessments of global cognitive 
functioning with questionable validity for PD samples. However, cognitive impairment 
correlated with generic burden measures, caregiver physical wellbeing, quality of life, 
the quality of the caregiver-receiver relationship, and financial burden. It tended not to 
impact on caregiver mood. Its relationship with burden may be mediated by patients‟ 
ability to complete daily living tasks, with one study directly examining this link. Only 
two studies examined whether impairments in specific cognitive modalities resulted in 
burden; results were contradictory and require further examination. 
  
Methodological weaknesses 
 
Studies used generic burden measures not validated with PD samples. A number of such 
measures were used across studies, with their questionable convergent validity resulting 
in difficulties comparing study findings. Since they are multidimensional in construct, 
studies‟ reporting of only the composite score meant that it was not possible to examine 
the impact of PD symptoms on specific aspects of burden. Whilst unidimensional 
measures were employed by some studies, this focused on caregiver mood and largely 
neglected other aspects of burden. 
 
Recruitment biases meant caregivers tended to be spouses; possibly affecting the 
validity of results for other caregiver/receiver relationships. Few studies ensured that 
„caregiver‟ participants were the primary caregivers or attempted to examine how much 
care was provided. Therefore they may not be ideal participants for examining how 
symptoms impact on burden. 
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The majority of studies limited their statistical analyses to correlation or between-group 
statistical analysis without matching groups or controlling for covariates. Since the 
severity of PD symptoms often inter-correlate this causes difficulties in determining 
whether the symptom under investigation is independently impacting on burden. Whilst 
some studies used regression to control for covariates, many had an insufficient sample 
size for the number of covariates included in the analyses.  
 
Finally, motor and cognitive symptoms were typically measured through composite 
scales such as the UPDRS and MMSE; the limitation being that it potentially obscures 
the impact of individual symptoms which may disproportionately predict burden.  
 
Clinical implications 
 
In the introduction to this review it was noted that the findings might suggest how 
caregivers could be supported by services. This review found evidence to suggest that it 
is not so much symptoms which impact on CB, but rather the patient‟s ability to 
complete daily living tasks (which in some cases may mediate any impact of certain 
symptoms). The finding of the salient role of patient functional disability in impacting 
on CB is in line with research in this area (Edwards & Scheetz, 2002). The reviewed 
studies did not examine why patient disability was so burdensome for caregivers, 
although one might hypothesise that it is due to increased caregiver workload. Services 
may be able to aid caregivers through supporting them with such tasks, providing 
respite, or working with care-recipients to enable them to function more independently. 
Clinical Psychologists may also be able to help caregivers adjust to their role and help 
them develop coping strategies to manage the increased demands placed on them. 
Interestingly a number of studies have revealed efficacious results from cognitive-
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behavioural interventions with PD caregivers around this area (A‟Campo et al, 2010; 
Secker & Brown, 2005). 
 
A further consideration was how PD treatment options might impact on CB. It was 
noted that STN-DBS has a differential impact across the PD symptom profile. 
Interestingly, whilst gait disturbance and postural instability were found to be the most 
burdensome motor symptoms for caregivers, they tend to be less well controlled by 
STN-DBS (Halpern et al, 2007). However, the finding that patient disability is a key 
predictor of burden offers more promise since STN-DBS can improve patients‟ ability 
to complete daily living tasks (Limousin et al, 1998). 
 
Directions for future research 
 
Future research would benefit from more consistency in the measurement of CB. 
Examination of the psychometric properties of these measures when applied to PD 
samples would be beneficial, as would an examination of the convergent validity of 
these scales with one another. Where studies choose to use generic burden measures, 
results would be enhanced through the reporting of scores on each of the questionnaire‟s 
dimensions, and their relationship with PD symptoms examined. More research is 
needed into the relationship between PD symptoms and caregiver physical, social, and 
financial well-being. Rather than measuring motor and cognitive symptoms through 
composite scales, examining the role of individual symptoms would be useful. A move 
away from cross-sectional studies would allow for examination of how symptoms 
predict future levels of burden. Related to this, a useful area of examination would be to 
study how symptom change following STN-DBS impacts on CB. 
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Limitations of this review 
 
The large number of studies included in this review meant that it was not possible to 
provide a detailed description and critique of each of the studies. Instead the critique 
primarily focused on weaknesses inherent across studies, such as limitations in the 
measures used. These seemed most salient since they provided some explanation for 
inconsistent results and are important considerations when approaching further research 
in this area.  
 
Whilst an examination of the predictive role of symptoms in causing CB is a valuable 
area of enquiry, a number of studies have found that their role is less significant than 
that played by such factors as patient and caregiver sociodemographics, personality 
factors and coping strategies (Hooker et al, 1998; 2000; Lyons et al, 2004). Therefore 
whilst the results of this review add to our understanding of the area, they need to be 
considered in the context of this wider research. 
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Abstract 
 
Deep Brain Stimulation (DBS) is a neurosurgical procedure that can improve certain 
Parkinsonian motor symptoms. Yet its impact across the wider symptom profile is more 
variable. Few studies have examined how service users evaluate this intervention. This 
study examines the expectations of DBS held by Parkinson‟s disease patients and their 
respective caregivers prior to surgery, the extent to which post-surgical evaluations of 
DBS involves discussion around similar themes to those discussed pre-surgery, and 
whether patients‟ and caregivers‟ perceptions of surgery differ. Eight patients and 6 
respective caregivers completed pre- and post-surgical interviews, with transcripts 
analysed using Template Analysis. Expectations of surgery centred on desired change in 
motor symptoms and quality of life. Subtle differences emerged between patients and 
caregivers in relation to quality of life expectations. All participants accepted that 
problems were likely to remain post-surgery, although their significance would be 
diminished. The occurrence of perioperative complications was expected to result in 
dissatisfaction. Post-surgery, evaluations of DBS continued to centre on changes in 
motor symptoms and quality of life. However, themes around fluctuations in 
improvement, the occurrence of new problems, and medical processes were also 
discussed. Again, only relatively subtle differences emerged in the accounts of patients 
and caregivers. Findings are discussed in relation to previous research around DBS, 
with clinical implications, study limitations and directions for future research proposed. 
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Introduction 
 
Parkinson‟s disease (PD) is a chronic progressive neurological disorder resulting in 
depletion of dopamine neurons in the substantia nigra. It is characterised by cardinal 
motor impairments, specifically tremor at rest, rigidity and bradykinesia, with additional 
axial symptoms including festinating gait and postural instability. PD affects 0.5% of 
people aged 65-74, and 1-2% of people 75 years and over, with about 10,000 people 
diagnosed each year, making it the second most prevalent neurodegenerative disorder 
behind Alzheimer‟s disease (National Collaborating Centre for Chronic Conditions, 
2006).  
 
Whilst primarily identified by its motor symptoms, PD is associated with significant 
psychiatric, behavioural and cognitive disturbance. With regard to psychiatric 
symptoms, 30-40% of sufferers are clinically depressed, with a similar percentage 
presenting with anxiety (Aarsland et al, 2009). More severe neuropsychiatric 
disturbances include psychotic symptoms such as visual hallucinations, which present in 
up to 25% of outpatients (Sanchez-Ramos et al, 1996). Behavioural impairments 
include apathy (Pedersen et al, 2009), sexual disturbance (Hand et al, 2010) and fatigue 
(Friedman et al, 2007), which present independent to mood disturbance. Cognitive 
sequelae are consistent with frontal-subcortical pathology and include impaired 
visuospatial skills, memory retrieval, executive functions and verbal fluency (Marder & 
Jacobs, 2008; Taylor & Saint-Cyr, 1995). A significant percentage of sufferers develop 
Parkinson‟s Disease Dementia, with clinical features resembling a progressive 
dysexecutive syndrome. Not surprisingly the quality of life of PD sufferers has been 
found to be reduced (Kuopio et al, 2000; Schrag et al, 2000). 
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Since the disorder was first documented in James Parkinson‟s „Essay on the Shaking 
Palsy‟ (Parkinson, 1817), 190 years of subsequent research has yet to produce a clear 
understanding of its pathogenesis and aetiology (Factor & Weiner, 2008). However, 
since the late 1960s there have been developments in the use of pharmacological 
treatments for the motor symptoms of PD, with drugs such as Levodopa aiding the 
production of dopamine in nigrostriatal neurons. Yet this treatment has a number of 
limitations. Its effectiveness over time diminishes and users experience unpredictable 
fluctuations between states of akinesia (i.e. lack of movement) and dyskinesia (i.e. 
uncontrollable movement), with the length of „on‟ periods (i.e. when medication is 
working) reduced. Medication has also been linked to neuropsychiatric disturbance, 
including psychotic symptomatology (Factor et al, 1995) and impulse control disorders 
(Dodd et al, 2005). 
 
In the past two decades there has been a resurgence of interest in the use of 
neurosurgical procedures to reduce the severity of cardinal symptoms of PD in patients 
who no longer respond significantly to medication. Ablative surgical techniques have 
largely been replaced by a potentially reversible lesioning approach known as deep 
brain stimulation (DBS). This neurosurgical intervention involves the stereotactic 
implantation of electrodes which deliver continuous high frequency electrical 
stimulation to a targeted area of the brain without the need to destroy brain tissue. A 
number of neuronal areas have been targeted in PD, although in recent years the 
subthalamic nucleus has become “the target of choice in most patients” (Lang, 2008, p. 
xiv). The mechanisms through which DBS works are not clearly understood, with 
stimulation appearing to produce both excitatory and inhibitory effects in surrounding 
neurons. Volkmann (2007) notes that deep brain stimulation of the subthalamic nucleus 
(STN-DBS) has a number of advantages over previous neurosurgery techniques: 1) it 
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does not involve destructive neuronal lesioning; 2) bilateral procedures are 
comparatively safe; 3) post-operative adjustment of stimulation parameters can improve 
efficacy, reduce adverse effects, and adapt DBS to disease progression; and 4) it can be 
reversed, thereby permitting the use of possible future interventions which require intact 
basal ganglia circuitry. 
 
Since lesioning of the subthalamic nucleus was first identified as an effective approach 
for reducing motor symptoms in Parkinsonian-induced primates (Aziz et al, 1991; 
DeLong, 1990), and the subsequent application of STN-DBS to human samples (Pollak 
et al, 1993), a wealth of research has amassed demonstrating the therapeutic value of 
STN-DBS. In reviewing the literature, Lozano et al (2004) conclude that its greatest 
impact on motor symptoms relates to improvement in dyskinesia and „on-off‟ 
fluctuations (i.e. the comparative severity of motor symptoms when patients are „on‟ 
medication versus „off‟ medication). Benefits are most noticeable when „off‟ medication 
states are compared pre- and post-surgery, with around a 40-60% improvement in motor 
scores on the Unified Parkinson‟s Disease Rating Scale. In addition to improvements in 
dyskinesia and medication use, a review by Halpern et al (2007) noted significant 
improvements in tremor, rigidity and bradykinesia. Improvements are still present 5 
years post-surgery (Benabid et al, 2001). Therefore, strong evidence exists supporting 
the beneficial use of STN-DBS in improving at least some PD motor symptoms, often 
with reductions in medication usage (Rodriguez-Oroz et al, 2005). In addition, reviews 
into its impact on quality of life also support its efficacy. Diamond & Jankovic (2005) 
reviewed eight studies with all noting improvements in overall quality of life. Subscales 
measuring mobility, activities of daily living, stigma, emotional well-being and bodily 
discomfort tended to show the largest improvements. Studies published subsequent to 
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this review draw similar conclusions and additionally note that benefits remain at two 
year follow-up (Lyons et al, 2005; Siderowf et al, 2006).  
 
These positive findings have meant that over 35,000 people worldwide have had DBS 
for treatment of tremor or Parkinson‟s disease (Volkmann, 2007) with estimates 
suggesting that 1 in 10 PD sufferers would be suitable for this treatment (National 
Institute for Clinical Excellence, 2003). Yet there is a danger of assuming that reduction 
in motor symptoms equates to patient satisfaction with treatment. There are a number of 
reasons why this presumption may be erroneous. Whilst STN-DBS typically results in 
improvements in dopamine-responsive symptoms, a number of other symptoms remain, 
progress or appear following surgery. STN-DBS has little effect on axial symptoms 
such as postural instability, speech and dysphagia (Halpern et al, 2007). It also fails to 
improve certain aspects of quality of life, notably social support, cognition and 
communication (Diamond & Jankovic, 2005). Some studies have found that, for a 
minority of patients, post-surgical emotional well-being deteriorates and rates of suicide 
increase (Berney et al, 2002; Voon et al, 2008). Cognitively, whilst most patients 
remain intact following surgery, declines in verbal fluency, speed of information 
processing, executive functioning, and working memory have been reported (Ardouin et 
al, 1999; Saint-Cyr et al, 2000; Woods et al, 2002; York et al, 2008). Around 41% of 
patients experience some cognitive deterioration post-surgery (Temel et al, 2006). 
Behavioural disturbances include increased apathy and irritability (Castelli et al, 2006; 
Houeto et al, 2002). The surgical procedure itself can result in complications, including 
intracranial bleeding, stroke, infection, eyelid opening apraxia, dysarthria, dysphagia 
and hardware-related problems (Limousin & Martinez-Torres, 2008). Another reason to 
suspect that improvements in motor symptoms may not equate to care-recipient 
satisfaction emanates from a study by Schüpbach et al (2006), who found that a 
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significant number of patients highlighted difficulties with social adjustment post-
surgery despite improvement in motor symptoms. In addition they reported that 58% of 
PD caregivers were disappointed with the results of STN-DBS.  
 
It is surprising that the investigation of patient satisfaction with STN-DBS has been 
given limited attention in the research literature up until now. Weaver et al (1997) 
highlight that “patient satisfaction is likely to be the distinguishing outcome of many 
treatments for chronic diseases for which living with treatment is a more realistic 
objective than cure” (p. 579). Indeed, patient satisfaction is a significant goal of medical 
treatment (Cleary & McNeil, 1988), with satisfied patients more likely to adhere to 
medical advice (O‟Brien et al, 1992; Sherbourne et al, 1992), show better health 
outcomes (Brody & Miller, 1986) and less likely to pursue legal action against the 
hospital for malpractice (Hickson et al, 1994). It is also an increasingly desired outcome 
in a health service that has over the past two decades seen a shift towards consumerism 
(Pager, 2004).  
 
Due to the lack of research into patient satisfaction following STN-DBS, it is unclear 
what factors impact on this variable. Many models of patient satisfaction propose that a 
salient predictor of this variable is the expectations held by patients (Ross et al, 1987; 
Weaver et al, 1997). Indeed Okun et al (2005) propose that research around STN-DBS 
should focus on understanding patients post-operative evaluations of surgery relative to 
their pre-surgical expectations. Yet investigation of this relationship has been lacking. 
Instead, trials of STN-DBS effectiveness have adopted a „top-down‟ approach whereby 
the value of this surgery has been measured against criteria deemed important by 
clinicians and researchers. What is needed is a more „bottom-up‟ approach whereby 
those factors deemed important by the patient are made prominent.  
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Furthermore, such research needs to provide a voice to those informal caregivers who 
play a significant role in supporting PD sufferers on a day-to-day basis. Research 
highlights the degree of burden experienced by this group. Estimates suggest that 
around 20% of PD caregivers have clinical levels of depression (Fernandez et al, 2001), 
with the demands of caregiving having a substantial impact on their social functioning, 
physical health, and relationships with other family members (Schrag et al, 2006). This 
group is therefore likely to hold expectations in relation to possible benefits from STN-
DBS. Dissatisfaction may impact on their ability to continue providing assistance.  
 
In the past decade there has been a rapid expansion in the use of qualitative 
methodologies in health care research (Pope & Mays, 2006). Quantitative studies have 
often been criticised for examining issues deemed important by investigators, but which 
may have little meaning for those individuals under investigation (Guba & Lincoln, 
1998). Qualitative methodologies in contrast provide a means through which care-
recipients can voice their perspectives and, through identifying aspects important to 
them, allow for subsequent quantitative examinations of the impact of any medical 
interventions on such factors. This author proposes that qualitative approaches provide 
an exciting opportunity to examine care-recipients‟ perceptions of STN-DBS, in 
particular the expectations they hold and the factors deemed important when evaluating 
its impact. 
 
The aim of this research is to examine the expectations patients with PD and their 
caregivers have in relation to STN-DBS prior to the patient undergoing surgery. In 
addition, the study aims to examine how these patients and carers subsequently evaluate 
surgery and the extent to which the criteria used to judge its success overlap with the 
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topics discussed pre-surgery. Finally, this study will examine whether the factors 
considered salient by patients overlap with those discussed by caregivers. 
 
 
Method 
 
Rationale for Design 
Given the exploratory nature of this research, a qualitative methodology was adopted. 
Semi-structured face-to-face interviews with patients and caregivers were undertaken, 
with each participant interviewed separately thus encouraging the discussion of themes 
important to them as individuals. The study was longitudinal, with pre-surgical 
interviews conducted in the days prior to surgery and follow-up interviews occurring 3-
6 months post-surgery. The time frame for follow-up was determined through 
consultations with service-users and a PD Nurse Specialist who felt it would provide 
sufficient time to appraise any surgical change. Follow-up interviews occurred as close 
to the 6 month mark as possible to facilitate this, although time constraints meant some 
were interviewed earlier. 
 
The desired sample size was 8 patients and their respective caregivers. This sample size 
falls within recommendations for the chosen data analysis approach, Template Analysis 
(King, 2004), and represents a realistic estimate of the number of patients likely to 
undergo STN-DBS during the course of this study. 
 
Participants 
Patients were recruited from NHS movement disorder clinics based at the John 
Radcliffe Hospital (Oxford) and the Royal Hallamshire Hospital (Sheffield). All had 
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undergone a routine pre-surgical assessment, ensuring they: (i) had idiopathic PD, (ii) 
presented with dopamine-responsive symptoms likely to improve following STN-DBS, 
(iii) were able to provide informed consent based on an accurate understanding of the 
likely benefits / risks of surgery, (iv) did not present with dementia, and (v) were free 
from psychiatric disturbance that might be exacerbated by surgery. All participants 
passed this health screen and were due to receive bilateral STN-DBS. 
 
A purposeful sampling strategy was adopted whereby patients were approached in the 
order in which they were due to undergo surgery. The first 8 to agree to participate 
comprised the study sample. This provided a „snap shot‟ of patients undergoing STN-
DBS which was free of recruitment bias, hence increasing the likelihood that their 
viewpoints would be representative of other surgical candidates. Potential participants 
were excluded if they had dementia, were unwilling / unable to commit to the follow-up 
interview, had difficulty conversing in English or had speech-language impairments 
(e.g. dysarthria) likely to affect the transcription of recorded interviews. The first 8 
patients that were approached all agreed to participate. They were asked to enquire as to 
their carer‟s willingness to participate. One patient did not have an informal caregiver 
present and another‟s caregiver did not wish to participate. The study sample therefore 
included 8 patients and 6 carers, with their details displayed in Table 1. 
 
Interviews 
Interview schedules (Appendix 4) for pre- and post-surgical discussions were designed 
to be open, non-leading and unambiguous, in line with recommendations by Breakwell 
(2002). They were piloted with service-users to ensure that questions were appropriate 
to the research question and would lead to detailed discussions.  
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Pre-surgery interviews were concerned with understanding participants‟ expectations of 
STN-DBS. In order to elicit information relevant to this research question, interviews 
focused on: 
 Life with Parkinson‟s disease and the reasons for seeking surgery. 
 Expectations of change from surgery. 
 Hopes around change from surgery. 
 How the effectiveness of surgery will be judged. 
 Aspects which are unlikely to change, or could deteriorate, following surgery. 
 
Post-surgical interviews were concerned with understanding the participant‟s 
satisfaction with STN-DBS and the factors central to this evaluation. In order to elicit 
this information, the following topics were discussed: 
 Reviewing pre-surgical expectations 
 Changes noticed since surgery 
 The most important changes since surgery  
 Factors that hadn‟t changed since surgery 
 Perceptions of the future and how this has been influenced by surgery 
 
Measures 
Elliot et al (1999) state that qualitative research should „situate the sample‟ through 
providing information that allows the reader to judge the „range of persons‟ 
participating in the research. Given that this study is concerned with an intervention 
designed to alleviate patients‟ symptoms, clinical details of the sample are presented in 
Figure 1 alongside sociodemographic characteristics. This information was obtained 
(with the patient‟s consent) from their routine pre-surgical medical evaluation, which 
involved administering the following measures: 
61 
 
 
 The Unified Parkinson‟s Disease Rating Scale – Motor Section (UPDRS; Fahn 
& Elton, 1987). This clinician-rated scale measures motor symptom severity, 
with scores ranging from 0 – 52. Higher scores indicate greater symptom 
severity.  
 
 The Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, 1983). 
This measures patient anxiety and depression on separate subscales, with scores 
greater than 10 suggesting clinical significance.  
 
 The Wechsler Abbreviated Scale of Intelligence (WASI; The Psychological 
Corporation, 1999), which provides a measure of general cognitive functioning. 
The Full-2 IQ score is presented which has a mean score of 100 with a standard 
deviation of 15. Higher scores indicate higher cognitive functioning. 
 
As a requirement for participation in this study, caregivers completed the Zarit Burden 
Inventory (ZBI; Zarit et al, 1980) which measures caregiver burden (Appendix 5). 
Scores range from 0-88, with higher scores indicating greater burden. The ZBI shows 
high internal consistency (α = 0.93) with PD caregivers (Martínez-Martín et al, 2007). 
Test-retest reliability has been found to be 0.71 (Zarit & Zarit, 1990). Scores on this 
measure were used to provide an indication of the impact of PD on caregivers. 
 
Patients and caregivers were asked to complete a visual analogue scale (Appendix 6) 
indicating their degree of satisfaction with STN-DBS using a scale of 0-100, with 
higher scores indicating greater satisfaction. 
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Table 1 – Details of Participants 
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Paul 
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* Patient age and disease duration are not specified exactly, so as to protect anonymity 
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Alex 
 
40-50 
 
10-15 
 
17 
 
2 
 
8 
 
127 
 
5 
 
Home 
 
Spouse 
 
11 
 
Pamela 
 
60-70 
 
10-15 
 
20 
 
4 
 
8 
 
109 
 
3 
 
Home 
 
N.A. 
 
N.A. 
 
Ewan 
 
80-90 
 
16-20 
 
28 
 
5 
 
9 
 
126 
 
3 
 
Clinic 
 
N.A. 
 
N.A. 
 
Ronald 
 
60-70 
 
10-15 
 
44 
 
9 
 
9 
 
117 
 
3 
 
Clinic 
 
Partner 
 
16 
64 
 
Researcher Characteristics 
Most qualitative traditions state that the ideological stance of the researcher is likely to 
influence the conduct and analysis of research. In this study the researcher was a third 
year Trainee Clinical Psychologist who was a 27-year-old White-British male who 
previously had been involved in a large multicentre trial examining the effectiveness of 
STN-DBS and its impact on neuropsychological functioning. As such he had significant 
experience of conducting clinical interviews with surgical patients and their carers both 
prior to and following STN-DBS. This included discussions around expectations and 
evaluations of surgical outcome. These experiences led the researcher to believe that 
STN-DBS can be a very effective treatment for motor symptoms in the majority of 
patients. Yet it was felt that outcomes from surgery can vary substantially with a 
minority experiencing deterioration in aspects of their symptom profile. 
 
Procedure 
The procedure for recruiting participants was slightly different between the two 
recruitment sites. At the John Radcliffe Hospital, a member of the movement disorder 
healthcare team provided potential participants with an information sheet (Appendices 7 
and 8) relating to this study during their stay on the hospital ward in the days leading up 
to surgery. Patients and carers subsequently informed the healthcare professional of 
their decision to participate, who in turn informed the researcher. Interviews were 
conducted in a private room within the hospital. 
 
For the Sheffield cohort, potential participants who were shortly due to undergo surgery 
were contacted by telephone by a member of the healthcare team. Patients who 
expressed a willingness to be contacted by the researcher were sent an information sheet 
by post. The researcher subsequently contacted the patient to enquire about willingness 
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to participate and arrange an interview time. Interviews took place in the participant‟s 
home and occurred roughly 2 weeks before surgery. 
 
On meeting with participants, all received spoken instructions as to the nature of the 
study, requirements of their participation, issues around confidentiality and consent, and 
their rights to withdraw. Participants were given the opportunity to ask questions prior 
to completing a consent form (Appendices 9 and 10). 
 
Patients and carers were interviewed separately. Each interview lasted approximately 30 
minutes. Afterwards, participants were given the opportunity to discuss any emotive 
issues that arose from the interview. Carers were asked to complete the ZBI. This 
measure was given following the interview so as not to prime participants‟ interview 
responses around domains assessed by the ZBI. The researcher took field notes around 
the interview experience. 
 
Patients‟ clinical and sociodemographic details (displayed in Table 1) were collected 
following the interview so as to minimise any assumptions about the participant that the 
researcher might take into the interview. 
 
Prior to follow-up, participants were contacted by telephone to confirm their willingness 
to undertake a further interview. Before contacting participants, the researcher enquired 
with the healthcare team whether surgery had been associated with any significant 
complications (e.g. death, stroke). This inquiry was designed to minimise any potential 
upset to the patient or family through the phone call. No further information regarding 
the patient‟s surgical outcome was requested.  
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Participants from the Sheffield site were again interviewed in their homes and Oxford 
participants interviewed during their stay on the hospital ward during routine post-
surgical medical assessments. Where possible, interviews were scheduled for 6 months 
post-surgery. Similar procedures to the pre-surgery interview were followed, with 
participants given information regarding the study and asked to sign a consent form. 
 
Following the interview both patients and caregivers were asked to rate their level of 
surgical satisfaction using the visual analogue scale.  
 
Data Analysis 
Interviews with participants were recorded and transcribed verbatim. Template Analysis 
(TA), as described by King (2004), was employed to analyse interview data. TA is a 
form of thematic analysis which involves developing a coding template to summarise 
themes considered relevant by the researcher, and then organise them into meaningful 
higher-order themes. Its ability to compare and contrast perspectives between groups 
was in line with this study‟s aims, in which themes are compared pre- and post-surgery 
as well as between caregivers and patients. TA is not fixed to a particular 
epistemological position and is therefore suitable for the subtle realist stance of this 
research. This epistemological position postulates that qualitative research should aim to 
explore an underlying reality, but unlike a pure realist position it accepts that the ability 
to examine that reality may be obscured by subjective biases in the research process 
(Mays & Pope, 2000). 
  
TA proposes that analysis may begin with a priori codes, which may be modified or 
rejected as new themes emerge from the data. This fits well with the stance of this study 
since research suggests that changes in motor symptoms and quality of life may well 
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feature in participants‟ accounts. At the same time, given our lack of understanding 
regarding the importance participants attach to such change, any analytical approach 
needs the flexibility to adapt to alternative perspectives that emerge from the data, with 
TA allowing for this.  
 
King (2003) describes a number of stages involved in the analysis of data using TA: 
 
1. Define a priori themes: Based on the research literature outlined in the 
introduction of this paper, it was expected that participants would discuss 
change in relation to : 
i. Motor symptoms associated with PD 
ii. Quality of life 
 
2. Transcribe interviews: The researcher transcribed the majority of interviews so 
as to become familiar with the content and context of the interview.  
 
3. Conduct initial coding of the data: Coding of interview transcripts was 
undertaken using an open coding procedure, whereby the researcher identifies, 
names, categorises and describes aspects of the interview transcript considered 
relevant to the research question by means of a succinct label. The first stage 
involved reading through the transcript and highlighting text that was perceived 
to relate to expectations/satisfaction with surgery. Following this, each 
highlighted aspect of the text was labelled through summarising its content and 
providing an interpretation of how it related to the research question. During 
coding, consideration was given to whether selected statements could be coded 
by a priori themes. When this did not accurately describe/interpret a statement 
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then an alternative code was proposed. Coding continued until all highlighted 
aspects of the text had been labelled. Once the entire transcript was coded, these 
codes were listed and the researcher began to explore how they could be 
grouped based on commonalities in their meaning. This phase led onto the 
development of the initial template. 
 
4. Develop an initial template: The initial template was developed from the first 
coded transcript. Emergent themes were grouped into a smaller number of 
higher-order themes which described broader themes in the data. The initial 
template should incorporate all relevant themes identified in the transcript. Four 
templates were produced: (i) Patient Expectation Template, (ii) Carer 
Expectation Template, (iii) Patient Satisfaction Template, and (iv) Carer 
Satisfaction Template. This meant it was possible to compare patient vs carer 
surgical perceptions as well as pre- vs post-treatment surgical perceptions. 
„Expectation‟ templates were produced following completion of all pre-surgical 
interviews. It was felt that producing the template prior to this could bias the 
interviewer to pursuing themes deemed salient by this analysis, thus potentially 
minimising the range of themes discussed by participants. The same approach 
was used to develop the „satisfaction‟ templates. 
 
5. Apply the template to the full data set: The comprehensiveness of the initial 
template was assessed through applying it to successive transcripts. The 
template was expected to be revised during this process. This involved insertion, 
deletion or modification of themes based on considerations emerging from the 
full data set. Where modifications took place, the accuracy of the template in 
describing preceding transcripts was reassessed. 
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6. Present the final template: The final template should provide a comprehensive 
overview of the themes relevant to the research question that have emerged from 
the transcripts.  
 
Reliability and Validity 
The epistemological stance of this research rejects the use of terms such as „reliability‟ 
and „validity‟ as defined by those of the pure realist tradition, whereby interpretation of 
data is seen as free of coder bias. Instead, TA proposes that researchers should 
demonstrate the „credibility‟ and „trustworthiness‟ of their analysis through a process of 
reflexivity and transparency (King, 2004). The following methods were used: 
 
1. The interview schedule was piloted with 5 PD service-users who had undergone 
STN-DBS. Their feedback on the appropriateness of the research questions for 
addressing the study‟s aims allowed the researcher to recognise and modify any 
personal biases in these questions.    
 
2. A reflective journal was kept by the researcher throughout the course of the 
study. In line with recommendations by Ortlipp (2008) it aimed to increase the 
researcher‟s awareness of how intrinsic biases impacted on the research process, 
data analysis, and derived conclusions. 
 
3. The development of the initial template took place alongside discussions with a 
Clinical Psychologist who independently coded two patient and caregiver 
interviews. She was a 27-year-old White-Asian-British Clinical Psychologist. 
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Her detachment from the field of movement disorders encouraged an „outsider 
perspective‟ on the themes discussed. 
 
4. The comprehensiveness of the final template was examined by asking a 
Consultant Clinical Neuropsychologist to apply the template to a randomly 
selected patient and caregiver transcript. He was a 57-year-old White-British 
male with 20 years experience of working within the movement disorder field. 
Discussion took place around the comprehensive of the template, and final 
refinements were made. 
 
5. An audit trail was kept, in line with recommendations by Wolf (2003). This 
made explicit the steps taken by the researcher from data collection through to 
the presentation of results. Transparency of the research process is facilitated 
through providing the reader with a detailed description of the research 
methodology. A worked example of TA applied to the data set is provided in 
Appendix 11. The presentation of results is „grounded in examples‟ using 
extracts from participant interviews. 
 
Ethical Considerations 
It was recognised that discussing surgery and the experience of having PD might be 
emotive for participants. Interview schedules were therefore piloted with volunteers 
from the Parkinson‟s Disease Society. All felt it was appropriately sensitive, but 
suggested providing participants with the opportunity to discuss any difficult issues 
following the interview. This suggestion was incorporated in the research procedure. 
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Participant information sheets and consent forms were also evaluated by this panel to 
ensure they were easily understandable and included an appropriate level of detail so 
that participants could make an informed choice as to whether to participate. 
Suggestions were incorporated into the final version of these forms. 
 
Participants were referred to by pseudonyms with any identifiable details altered or 
omitted, thereby ensuring anonymity. Where transcription of interviews was undertaken 
by an employed transcriber, this individual signed a confidentiality agreement 
(Appendix 12). 
 
Prior to the commencement of this research, it underwent ethical review from the South 
Yorkshire NHS Research Ethics Committee. This panel approved the study (Appendix 
3). 
 
 
 
Results 
 
1. EXPECTATIONS OF SURGERY 
 
Whilst separate templates were produced for patients and caregivers, there was 
significant overlap in the themes discussed. As such Table 2 shows a combined 
template, with themes discussed solely by either patients or carers highlighted in italics. 
This section will therefore discuss each of these themes, with extracts from participant 
interviews shown in italics. 
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Table 2 – Template of Participants‟ Expectations 
 
1. EXPECTATIONS OF SURGERY 
1.1 CHANGE FOLLOWING SURGERY 
 1.11 Improved motor symptoms and medication 
 1.12 Improved quality of life 
 (1) Daily living tasks 
 (2) Hobbies 
 (3) Employment opportunities – (P) 
 (4) Socialising 
 (5) Self-image 
 (6) Freedom / Independence 
 (7) Emotional well-being – (C) 
 (8) Patient safety – (C) 
 1.13 Uncertainty around change 
 1.14 Hearing about others – (P) 
1.2 PROBLEMS LIKELY TO REMAIN 
 1.21 “Not a cure” 
 1.22 “Hadn’t thought about it like that” 
 1.23 Reduced significance of remaining symptoms 
1.3 HOW SURGERY WILL BE JUDGED 
 1.31 Size of motor symptom improvement 
 1.32 Markers of improvement 
 1.33 Complications 
 
(P) – Themes discussed solely by patients; (C) – Themes discussed solely by caregivers 
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1.1 CHANGE FOLLOWING SURGERY 
 
1.11 IMPROVED MOTOR SYMPTOMS AND MEDICATION 
 
All participants (patients and carers) expected improvements in motor symptoms and/or 
medication. A range of symptoms were discussed. Improvements in involuntary 
movement (dyskinesia) were mentioned by all participants: 
 
“The dyskinesia is the major, major thing at the moment ... 
As much as I know about Deep Brain Stimulation, I 
understand that that is what it‟s designed to do.” (David‟s 
carer) 
 
 
Improvements in cardinal motor symptoms were raised by many, most commonly in 
relation to stiffness and bradykinesia. Less severe and more predictable fluctuations in 
symptoms were discussed, with Pamela describing this as a desire for “a more even 
day.” Some felt gait would improve due to reduced stiffness, with David noting how 
“when my muscles bind up tight I can‟t walk.” Only a few participants felt surgery was 
likely to improve their balance. Patients and caregivers did not differ in relation to 
expectations around symptoms. 
 
1.12 IMPROVED QUALITY OF LIFE  
 
All participants expected an “improvement in quality of life” (Alex) through reduced 
motor symptoms. A range of areas fell under this heading: 
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1.121 Daily living tasks 
 
Participants expected patients to show improved ability in completing day-to-day tasks. 
Patients described how various symptoms affected their competence in these areas. 
Kathy noted that dyskinesia caused her to “throw things across the room”, whilst 
stiffness meant “tasks take longer to do.” She hoped surgery would improve such areas: 
 
“It‟d be nice to be able to stir up a pot or cut up things.” 
 
Caregivers also expected improvements. For some this was important due to its 
symbolic value. David‟s carer noted it would show “he can do normal things that you 
and I can do.” Others discussed the increased burden placed on them by the patient‟s 
disability, with Paul‟s carer stating “I‟m the one that‟s doing more.” 
 
1.122 Hobbies 
 
Patients discussed expectations around ability and desire to engage in hobbies. Some 
noted that increased disability had reduced their enjoyment of such pursuits: 
 
“It‟s kind of a struggle rather than an enjoyment 
sometimes.” (Alex) 
 
For others, motor symptoms had meant that pursuing such hobbies had become 
impractical: 
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“One has to think how you‟re going to organise the whole 
thing – where is the bathroom, how am I going to get there 
and do I need my wheelchair.” (Ewan) 
 
Caregivers also expected improvements, with Paul‟s carer hoping “he will be able to go 
and play golf again, he will be able to go fishing again, he will be able to play green 
bowls.”  
 
1.123 Employment opportunities 
 
Patients alone discussed expectations around surgery improving their ability to engage 
in employment. Most were unemployed and felt that surgery could help them gain 
employment, with Kathy reporting “I‟d be able to get a job again”. The only patient 
that was currently employed noted: 
 
“That‟s another thing about me having the operation is 
to prolong my work time.” (Alex) 
 
1.124 Socialising 
 
All participants expected surgery would improve their ability to spend time with others. 
Patients described a current lack of desire to socialise due to “embarrassment” 
(Ronald) around dyskinesia. Being “on the go all the time with people looking” (Kathy) 
made patients feel “awkward” (Alex). Socialising with strangers was particularly 
unpleasant: 
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“You walk in anywhere new and all eyes are on you 
because you‟re twisting away.” (Ronald) 
 
Some also spoke of how motor symptoms affected their social skills: 
 
“I have to concentrate on silly things instead of 
concentrating on what‟s going on around me.” (Alex) 
 
Through doing so Alex noted that he does not “contribute as much” to conversation 
which “isn‟t really the point of going out.” 
 
Caregivers also hoped that through the surgery the patient “would want to be a bit more 
social” (David‟s carer). They recognised the patient as “being embarrassed” (David‟s 
carer) by their symptoms, noting patients would “sometimes decline invitations because 
he never knows how bad his symptoms are going to be” (David‟s carer).  
 
Carers also felt that their own social lives had suffered and hoped for improvements. 
Paul‟s carer noted her enjoyment of socialising had diminished due to feelings of 
“guilt” when socialising whilst her husband was forced to be at home. She hoped 
surgery would “get his social life back” because then she would be “entitled to do that 
(socialise) as well.” 
 
1.125 Self-image 
 
Patients spoke of reduced self-confidence due to motor symptoms and hoped this would 
change. Increased perceptions of disability caused some to note “your confidence goes” 
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(Paul), with surgery expected to allow them “to feel useful again” (Paul). Others spoke 
of a desire to be “normal” (Ronald) or “more human again” (Ronald), with this 
negative image formed by the reaction of others: 
 
“You see a Mum and her children kind of look the other 
way, cross the road, in case there‟s something weird about 
me.” (Ronald) 
 
Caregivers also expected surgery would “give him his confidence back” (Paul‟s carer) 
and allow the patient “to feel normal” (Ronald‟s carer). One caregiver felt that her 
husband‟s lack of confidence caused him to be “neurotic ... always looking around to 
see what other‟s reactions to things are” (Matthew‟s carer). She felt this caused her 
husband to be defensive and hoped increased confidence would allow him to “accept 
that he‟s wrong sometimes.” 
 
1.126 Freedom / Independence 
 
Patients spoke of life lacking “freedom” (Pamela) in which there was “no spontaneity” 
(Pamela), often as a result of unpredictable „on-off‟ fluctuations: 
 
 “We don‟t do things because we don‟t know how I‟m going 
to be in 20 minutes.” (Paul) 
 
Pamela noted that motor symptoms amounted to a “loss of independence” in which she 
was “increasingly reliant on others.” She hoped surgery would offer the “freedom to 
do what I want, when I want.” 
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Caregivers also expected more independence/freedom. For most, they expected 
increased patient independence/freedom to result in more enjoyable time spent with the 
patient where there was “more scope to go somewhere and do something” (Ronald‟s 
Carer). For others, increasing the patient‟s independence was expected to lead to their 
own independence. They spoke of feeling “trapped by Parkinson‟s” (Paul‟s carer) and 
hoped: 
 
 “If he gains his independence, he‟ll be less dependent on 
me.” (Matthew‟s carer) 
 
1.127 Emotional well-being 
 
Caregivers alone explicitly discussed the expected impact of surgery on the patient‟s 
mood. They noted that symptoms “must get him down” (David‟s carer), with one carer 
noting her main aim of surgery was “for him to be happy” (Paul‟s carer). 
 
Caregivers also expected improvements in their own mood. David‟s carer noted that 
seeing her brother overcome by his symptoms “breaks my heart” and Ronald‟s carer 
commented that the social stigma her partner experiences around his symptoms causes 
her to feel “hurt that people can treat someone like that.” Others spoke of reduced 
“guilt” (Paul‟s carer) at pursuing their own social lives if the patient was more 
independent, whilst Matthew‟s carer hoped she would feel less “resentful” if her 
husband was less dependent on her following surgery. 
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1.128 Patient safety 
 
Caregivers alone spoke of hoping surgery would improve the patient‟s safety. They felt 
they “had to keep an eye on him (the patient) all the time” (Paul‟s carer) causing them 
to feel “afraid” (David‟s carer). 
 
1.13 UNCERTAINTY AROUND CHANGE 
 
A number of participants felt uncertain as to what might change following surgery. 
Some highlighted that “every surgery done on every Parkinson‟s sufferer is likely to 
have a different effect” (Paul‟s carer). Many accepted this lack of certainty through 
placing their faith in the treating clinician‟s judgement: 
 
“If the powers that be didn‟t think that he was an ideal 
candidate then they wouldn‟t have put him forward” 
(Paul‟s carer). 
 
Similarly, Ronald noted “I haven‟t really been told that much about it ... I just know 
that the people who are doing it are very capable and I trust in them completely.” 
Others accepted the lack of uncertainty since they felt there were no other treatment 
options available. Alex‟s carer noted “with Parkinson‟s pretty much anything you are 
doing is experimental”, but highlighted “what is there on the horizon for people with 
Parkinson‟s? Well, not a great deal”.  
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1.14 HEARING ABOUT OTHERS 
 
Patients alone discussed how their expectations were based on hearing about others 
undergoing STN-DBS. In all cases, stories involved positive change. Some patients 
spoke of media stories: 
 
“I read about this guy who was a professional golfer in 
the States who‟d had deep brain stimulation and went 
back and became a professional golfer again, so I 
thought „well that can‟t be too bad‟.” (Paul) 
 
 Others spoke of hearing „stories on the hospital ward‟ about “incredible” (Ronald) 
changes in others, leading them to conclude: 
 
 “Well if it works for them, it must work for me.” 
(Ronald) 
 
1.2 THINGS LIKELY TO REMAIN THE SAME 
 
1.21 “NOT A CURE” 
 
All participants noted that surgery was “not a cure” (Paul) and that problems would 
remain: 
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 “It won‟t change the fact that I‟ve got it (Parkinson‟s), 
and I understand it doesn‟t affect the development of 
the disease.” (Alex) 
 
1.22 “HADN‟T THOUGHT ABOUT IT LIKE THAT” 
 
A number of patients and carers alike noted that they had given little consideration to 
what problems might remain following surgery. Alex commented “I‟ve not thought 
about if it doesn‟t work”, whilst Ronald‟s carer emphasised: 
 
 “I‟m not looking at that, I‟m looking at things that are 
going to get better.” 
 
A number of patients and carers spoke of an optimistic perspective: 
 
 “I hadn‟t thought about that. I‟m thinking of the half-
full versus half-empty, and I work on the half-full.” 
(Matthew) 
 
Similarly, Paul‟s carer noted that “there‟s too many positives to it to actually worry 
about negatives.” 
 
1.23 REDUCED SIGNIFICANCE OF REMAINING PROBLEMS 
 
Participants believed some problems would remain, but felt that their significance 
would be diminished. Alex noted that whilst postural instability was likely to remain, 
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“if the rest of my symptoms are better then I‟ll be able to concentrate more on doing 
that (retaining balance).” Caregivers took a similar approach, with David‟s carer noting 
that whilst falling is likely to remain, the risk posed by this is minimal: 
 
 “He knows when he is going to fall and he falls very 
well actually.” 
 
Some patients even joked about the significance of the remaining symptoms. Pamela 
commented “well I‟m sure I shan‟t be able to run a mile”, and when discussing any 
new restrictions that might result from surgery Paul joked “well I‟ve been told I can‟t 
bungee jump – quite a relief really!”  
 
1.3 HOW SURGERY WILL BE JUDGED 
 
1.31 SIZE OF MOTOR SYMPTOM IMPROVEMENT 
 
Most participants spoke of judging surgery by the extent to which motor symptoms 
improved. All noted that dissatisfaction would occur “if you had no improvements in 
your symptoms” (Alex‟s carer). The degree of satisfaction would correspond to the 
magnitude of the improvement, with some improvement expected and large 
improvements seen as a possibility: 
 
“If it stops it (dyskinesia) completely I‟ll be extremely 
happy. But if it just goes a bit, then I‟ll still be okay 
about it. Just as long as it goes a bit.” (Kathy) 
 
83 
 
1.32 MARKERS OF IMPROVEMENT 
 
Participants varied in the extent to which they felt it would be possible to judge 
surgery‟s effectiveness through objective markers, with some noting “I‟ll just know” 
(Alex). However, many participants expected they would measure their satisfaction 
against the patient‟s functional ability: 
 
“If one looked at one‟s diary and saw what you‟ve done 
over the last three months (since surgery), and what 
you couldn‟t have done before.” (Ewan) 
 
1.33 COMPLICATIONS 
 
Complications arising from the surgery were viewed as a factor likely to lead to 
dissatisfaction. Participants spoke of surgical side effects, such as stroke, as being “a 
really bad outcome from our point of view” (Alex‟s carer). Other surgical side-effects 
discussed by participants included “paralysis” (Matthew‟s carer), “a bleed on the 
brain” (Pamela), and “being alive but a vegetable” (Paul). 
 
One caregiver noted that surgery could also lead to complications in the patient‟s motor 
symptoms profile; a possibility that would lead to dissatisfaction: 
 
“There is a risk that he might develop other symptoms, 
or something might become worse than it was before.” 
(Alex‟s Carer) 
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2. SATISFACTION WITH SURGERY 
 
Following post-surgical interviews, patients and caregivers rated their satisfaction with 
surgery. Results are displayed in Table 3. It shows a wide range of scores, with the 
majority of participants indicating overall satisfaction with treatment. 
 
Table 3 - Satisfaction with Surgery 
 
Patient 
Pseudonym 
Patient Satisfaction 
with Surgery 
Carer Satisfaction 
with Surgery 
Kathy 59 75 
Matthew 50 45 
Paul 96 95 
David 65 76 
Alex 81 90 
Pamela 85 N.A. 
Ewan 18 N.A. 
Ronald 100 100 
 
Whilst separate templates were produced for patients and caregivers, there was again 
significant overlap in the themes discussed. A combined template is displayed in Table 
4, with themes discussed solely by patients or carers highlighted in italics. 
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Table 4 - Template of Post-surgical Evaluations 
 
2. SATISFACTION WITH SURGERY 
 
2.1 EVALUATIONS OF MOTOR SYMPTOM CHANGE 
2.11 Change in motor symptoms and/or medication 
 2.12 Balancing up change across motor symptoms 
 2.13 Progressive change / changing satisfaction 
2.2 EVALUATIONS OF CHANGE IN „QUALITY OF LIFE‟ 
 2.21 General functional ability – (P) 
 2.22 Daily living tasks 
 2.23 Socialising 
 2.24 Self-image 
 2.25 Freedom / Independence 
 2.26 Emotional well-being 
 2.27 Patient safety – (C) 
2.3 UNEXPECTED IMPACT OF THE STIMULATOR 
2.31 Discomfort from the stimulator 
 2.32 Side effects / new symptoms 
2.4 MEDICAL INTERVENTIONS 
2.41 The surgical procedure – (P) 
2.42 The process of stimulator adjustment 
 2.43 The role of the medical team 
 
(P) – Themes discussed solely by patients; (C) – Themes discussed solely by caregivers 
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2.1  EVALUATIONS OF MOTOR SYMPTOM CHANGE 
 
2.11 CHANGE IN MOTOR SYMPTOMS AND/OR MEDICATION 
 
All participants evaluated surgery by its impact on motor symptoms and/or medication.  
Reductions in medication or motor symptom severity were evaluated positively. 
Desirable improvements were reported in „off‟ medication states, gait, balance, and „on-
off‟ fluctuations. The most common improvement was reduced dyskinesia: 
 
“Well the main thing was my involuntary movements 
have completely gone, which is really good.” (Alex) 
 
Where symptoms deteriorated there was dissatisfaction. Two patients and their 
respective caregivers spoke about worse „off‟ states. Kathy noted “now I am all 
stiffness” whilst David stated “I am much slower”. This had knock-on effects on their 
gait, with David commenting “I am stiff and can hardly walk.” Ewan also discussed 
frustration with a deterioration in the quality of his movement when „on‟ medication. 
Where there was no change across motor symptoms this also led to dissatisfaction. 
 
2.12 BALANCING UP CHANGE ACROSS MOTOR SYMPTOMS 
 
Patients varied in the extent to which they experienced improvement across motor 
symptoms. Some noted “everything has got better” (Alex), yet most reported that 
improvements in certain symptoms were accompanied by deterioration in others. 
Participants described evaluations of surgery as involving „balancing up‟ the impact of 
their new motor symptom profile. David spoke of improved dyskinesia but worse 
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stiffness, leading him to conclude “I‟ve exchanged one thing for another.” However, he 
evaluated surgery overall as a success stating “to get rid of dyskinesia was the main 
thing. That was terrible.” Kathy also found that post-surgery she had reduced 
dyskinesia and worse stiffness: 
 
“I must admit I don‟t shake as much as I did before I 
went in. But now I am all stiffness.” 
 
In contrast to David, she concluded that stiffness was a greater problem, commenting 
“well if I can‟t move, I can‟t do anything. I need to walk!” 
 
2.13 PROGRESSIVE CHANGE / CHANGING SATISFACTION 
 
All participants spoke of fluctuating levels of symptom change over time which had a 
resultant impact on their satisfaction. All noted positive change immediately post-
surgery. However, most found that improvements deteriorated during the post-operative 
recovery period. David‟s carer described how “once he had the operation to sink the 
wires into his chest he seemed to go downhill a bit.” She described this experience as 
“heartbreaking”.  
 
Most participants noted how symptoms improved again as the medical team adjusted 
the stimulator. Yet Pamela highlighted “I haven‟t quite got back to where I was then”, 
the impact being “a bit annoying because I had tasted how much better it was.” 
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The pace of change impacted on participants‟ satisfaction, as discussed by Paul and his 
carer. Paul commented “it has taken me longer to achieve that (desired motor symptom 
reduction). I rather thought it would probably be more instant.” He noted: 
 
“I think now I‟ve had the chance to live with it for 5 
months I‟ve got a much better appreciation of what it 
has achieved for me ... I‟ve got a much happier 
relationship with it than I did probably a couple of 
months ago.” 
 
One patient and his carer described a process of “one step forward, two steps back” 
(Matthew) in relation to temporary symptom improvement following stimulator 
adjustment which subsequently remitted after a few days: 
 
“What has changed?! Nothing has changed! It‟s 
temporarily improved and when it has improved it has 
been good, but it hasn‟t lasted.” (Matthew) 
 
2.2  EVALUATIONS OF CHANGE IN „QUALITY OF LIFE‟ 
 
Participants described their evaluations of surgery being linked to how motor symptom 
change impacted on „quality of life‟. The manner in which this was conceptualised by 
participants is outlined below. 
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2.21 GENERAL FUNCTIONAL ABILITY 
 
Patients alone evaluated surgery in terms of their functional ability in undertaking tasks. 
Rather than specifying a context in which this occurred, patients talked more generally 
of this improvement/deterioration in ability. Where patients were pleased with surgery 
they spoke of being able to do things “quicker and better now” (Alex). Dissatisfaction 
arose when patients felt “clumsier” (Ewan) or they “couldn‟t do anything” (Kathy). 
 
2.22 DAILY LIVING TASKS 
 
Participants evaluated surgery by its impact on the patient‟s ability to complete daily 
living tasks. Patients spoke of increased ability to do things and improvements in the 
quality of how tasks were completed. Pamela noted “I do much more housework than I 
used to” and Ronald commented such tasks “were much easier because I don‟t shake 
so much.” Paul felt such changes had “totally transformed my life.”  
 
Caregivers also spoke of evaluations around such tasks, but more so around its symbolic 
value:  
 
“Sometimes it‟s these really small things that you 
think „five months ago he couldn‟t do that and now he 
can‟.” (Alex‟s carer)  
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2.23 SOCIALISING 
 
Participants evaluated surgery by its impact on the patient‟s level of social functioning. 
Patients described feeling less uncomfortable in social situations. Pamela noted reduced 
dyskinesia meant “I do feel I can go out more and be in company” and described this 
change as “great”, highlighting “I haven‟t been out like that in ages”. Increased social 
activity was also facilitated by reduced disability. Paul‟s renewed ability to drive meant 
“I can travel locally to see friends.” Dissatisfaction arose when patients felt that they 
were unable to fully participate in social events. Ewan felt his poorer „on‟ periods meant 
he enjoyed socialising less since he had to “desperately try to keep up” with what was 
going on around him. 
 
Caregivers also evaluated surgery under this theme. Some noted desirable increases in 
social activity. Ronald‟s carer highlighted that previously “he shied away from things 
because people looked at him. But now that‟s fine.” Others highlighted the importance 
of the patient enjoying such activities. Alex‟s carer noted that “he has really enjoyed 
that (socialising again) and consequently I‟ve enjoyed that.” 
 
2.24 SELF-IMAGE 
 
Participants evaluated surgery by whether it had resulted in patients holding a more 
positive self-image. Patients reported desirable changes in their confidence. Alex 
commented “I feel more confident about it (Parkinson‟s) and myself again, just like I 
used to be.” Others spoke of how surgery had allowed them to reclaim their identity: 
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“(Prior to surgery) My position as breadwinner had 
changed and I felt as though  I was losing my position 
as husband and father as well and I just felt as though I 
was being rubbed out of the equation ... Now I feel that 
has changed. I haven‟t got back my position totally, but 
I‟m now a fully paid up member of the household 
again.” (Paul) 
 
Some patients described negative changes in self-image as impacting on their 
evaluations of surgery. On discussing the deterioration in his „off‟ state, David noted “it 
makes you feel like an old man, in his 80s” and reflected “I‟m well past my shelf life.”  
 
Caregiver‟s also evaluated surgery under this theme. Alex‟s carer noted “he‟s much 
more confident, more relaxed, his old personality has kind of come back and that‟s just 
amazing to see.” However, Matthew‟s carer was disappointed that since STN-DBS her 
husband continued to have “a lack of confidence” which meant he “just sits at home all 
day.”  
 
2.25 INDEPENDENCE / FREEDOM 
 
Patients evaluated surgery based on whether it had increased their independence / 
freedom. Matthew noted that his improved ability to dress himself was “good as I am 
less dependent upon people doing up my buttons.” Paul noted that surgery “has given 
me back my freedom.”  
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Caregivers also evaluated surgery under this theme. Ronald‟s carer felt that the greatest 
benefit of his reduced dyskinesia was that “it gives him more freedom.” Paul‟s carer 
noted that surgery “just makes life so much more free” noting “he has begun to get his 
independence back.” Carers also spoke of the impact on their own independence / 
freedom. Paul‟s carer noted that her husband‟s increased independence had “relieved 
some of the pressures from me” noting that now “I have taken more time for me.” 
Where surgery had not resulted in increased patient/carer independence, this was 
appraised negatively. Matthew‟s caregiver noted frustration that since surgery she still 
has “to give up what I want to do so that he can go somewhere or do something.” 
 
2.26 EMOTIONAL WELL-BEING  
 
Both patients and caregivers evaluated the impact of surgery on the patient‟s mood. 
Patients who evaluated change under this theme talked of surgery reducing their 
emotional well-being. David noted that he gets “very depressed at times”, stating that 
since surgery “I‟m not interested in a lot of things now.” Kathy spoke of having 
“emotional problems” and “crying all the time” 
 
In contrast, when caregivers spoke of evaluating surgery around the patient‟s mood, 
they spoke of improvements. Ronald‟s carer noted that “he is not as moody as he used 
to be”. Paul‟s carer felt that without surgery “he would have very easily spiralled into 
quite a deep depression” and concluded “personally I‟m glad I didn‟t have to go 
there.” 
 
Caregivers alone evaluated surgery‟s impact on their own mood. Paul‟s carer noted 
“there‟s less mental stress” whilst Alex‟s carer felt “it has created some hope in 
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something that is pretty hopeless.” Yet Matthew‟s carer was disappointed that surgery 
had not reduced her feelings of “guilt”. 
 
2.27 PATIENT SAFETY 
 
Caregivers alone spoke about evaluating surgery based on its impact on patients‟ safety. 
Ronald‟s caregiver noted “I used to worry an awful lot. I don‟t so much now.” Similarly 
Paul‟s carer noted: 
 
“I don‟t have to be constantly worrying „what is he up 
to, what is he doing?‟ I don‟t have to ring three or four 
times a day just to say „are you alright‟.” 
 
2.3  UNEXPECTED IMPACT OF THE STIMULATOR 
 
2.31 DISCOMFORT FROM THE STIMULATOR 
 
Patients alone spoke of unexpected discomfort from the apparatus used to power the 
deep brain stimulator. Two patients spoke of „body image‟ discomfort in relation to the 
prominence of the battery pack implanted in the chest, with Pamela commenting:  
 
“I am a bit self-conscious of the stimulator. I was 
expecting it would be much further under the skin.”  
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Alex also assumed “it would be like a little pacemaker thing”, highlighting “it just 
would have been nice to know.” Patients also described physical discomfort from the 
wires that run under the skin to power the stimulator: 
 
“I can feel the tube under my skin and I don‟t like to 
sleep on my left side because of the fact that I think I 
might press on it, so I have forced myself to sleep on my 
back.” (Ewan) 
 
Ewan stated this made him feel “vulnerable” and noted “I suppose it wouldn‟t bother 
me, but amazingly it does.” 
 
2.32 SIDE EFFECTS / NEW SYMPTOMS 
 
Patients and caregivers spoke of evaluating surgery on side effects from stimulation. 
The extent to which these unexpected changes impacted on satisfaction differed in 
relation to what had been affected. Where motor symptoms deteriorated this was 
perceived as an unexpected negative effect of the stimulator, with David noting “I 
didn‟t think it would send me back to this stiffness.” However, a number of non-motor 
symptom side effects were also reported. Weight gain was reported by participants and 
was generally appraised positively, with Pamela noting “it makes me look better than I 
was. I was looking a bit haggard before.” A number of patients and carers noted an 
unexpected and undesirable impact on the clarity of the patient‟s speech, which Paul 
noted was “completely new since they turned up the setting (on the stimulator).” He felt 
“a slight cautionary note might have been helpful.” Patients and carers reported 
negative effects on the patient‟s mood. Paul, Alex and Kathy described being “weepy”, 
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which Alex explained as “crying for a reason, but I wasn‟t really sure why or what the 
reason was.” One patient (David) felt the stimulator had made him “mentally slower”. 
 
2.4 MEDICAL INTERVENTIONS 
 
2.41 THE SURGICAL PROCEDURE 
 
STN-DBS is a neurosurgical procedure conducted under local anaesthetic. Patients 
discussed evaluations around the surgical procedure itself. For those patients that 
provided positive evaluations of the procedure, this often centred on the length of time 
in surgery: 
 
“The surgery wasn‟t nearly as bad as I thought, 
because I was really scared. Everything went so 
smooth. The team was wonderful and everybody was 
relaxed. It was so quick.” (Kathy) 
 
However, a number of patients found surgery unpleasant, with Pamela describing it as 
“traumatic”. She noted “it wasn‟t pain as such, but it was very very uncomfortable.” 
Ronald described discomfort during the subsequent subcutaneous implantation of the 
wires leading from the electrode: 
 
“When they shoved the wires down – that bloody hurt!”  
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2.42 THE PROCESS OF STIMULATOR ADJUSTMENT 
 
In the months after surgery, a number of „stimulator adjustments‟ take place during 
which the strength of the pulse emitted by the stimulator is altered in an attempt to 
maximise symptom reduction. Both patients and carers discussed dissatisfaction relating 
to this process. Ewan described it critically as “more of an art than a science”, noting 
bewilderment at why the adjustment process was conducted in an „off‟ medication 
rather than „on‟ medication state:  
 
“I don‟t think the adjustments have been done as 
cleverly as they might have been ... I have suggested 
several times, why don‟t they try me at my best rather 
than at my worst. I guess they understand the 
procedure and I don‟t. I just want them to get on with 
it.”  
 
Caregivers also described frustration around this process. David‟s carer noted confusion 
regarding the hospital‟s “reluctance to what they call „tweak it‟, they don‟t want to do 
that for whatever reason.” One caregiver noted the inconvenience of the repeated 
hospital appointments: 
 
“It‟s something that I don‟t feel is thought about to be 
quite honest. And I do accept that having a hospital 
appointment can be difficult and I wouldn‟t expect it on 
that day or that day, but it always seems to be at the 
worst time.” 
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2.43 THE ROLE OF THE MEDICAL TEAM 
 
Patients, and in particular caregivers, highlighted the role of the medical team in 
impacting on their satisfaction. Patients made general statements such as “the team was 
wonderful” (Kathy) or “they were absolutely fantastic” (Paul). Caregivers were more 
specific in their evaluations and spoke of the importance of staff being supportive, with 
Ronald‟s carer noting “there is always someone there”. Staff were seen to play a key 
role in the provision of information. Where this occurred this increased carer 
satisfaction, with Alex‟s carer commenting “the team is a huge support in the whole 
process because they are preparing you mentally for what is going to happen.” In 
contrast, Paul‟s carer felt the team could have provided more information: 
 
“Nobody had actually given us an idea of the recovery 
period, the actual getting over the surgery, and what to 
expect immediately after the surgery ... We would have 
benefitted from somebody just saying „don‟t expect this, 
don‟t expect that‟.” 
 
Satisfaction increased when caregivers felt included in the decision making process, 
with Alex‟s carer noting “You do feel that you are in partnership with them. It‟s like 
you are working on the same project if you like.” In contrast, Matthew‟s carer felt 
frustration that she was left „out of the loop‟: 
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“I don‟t feel I am particularly involved. I feel that 
(patient) will tell them what he wants them to know, but 
my opinion isn‟t sought.” 
 
 
Discussion 
 
This section summarises the themes discussed by participants and how these overlap 
with theoretical considerations of the efficacy of STN-DBS as well as the wider 
literature around expectations / satisfaction with medical care. This author will outline 
the clinical implications of these findings, comment on the strengths and weaknesses of 
this study, and suggest directions for future research.  
 
Expectations of STN-DBS 
 
All participants expected surgery to improve motor symptoms and/or medication. This 
included reduced dyskinesia, less severe „off‟ medication symptoms, less severe and 
more predictable „on-off‟ fluctuations, and improved gait. Patients and caregivers 
expected change in similar symptoms. Siddiqui et al (2008) emphasise the importance 
that patients have „realistic‟ expectations of STN-DBS. In this regard, the symptoms 
described were „realistic‟ targets since research finds them most amenable to 
improvement (Halpern et al, 2007; Lozano et al, 2004).  
 
All expected that improved motor symptoms would improve „quality of life‟. A range of 
themes fell under this heading, specifically daily living tasks, hobbies, employment, 
socialising, self-image, independence, mood, and patient safety. Most were „realistic‟ 
expectations when considering research evidence around quality of life change 
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following STN-DBS (Diamond & Jankovic, 2005). Within these areas, differences in 
patient and carer expectations became apparent. Firstly, whilst patients spoke of hopes 
around employment, this was not salient for caregivers. In contrast, caregivers hoped 
surgery would improve mood (both their mood and the patient‟s) and patient safety. The 
importance attached to mood may relate to consistent findings of caregiver depression 
in PD (Dura et al, 1990; O‟Reilly et al, 1996) and the reciprocal relationship between 
caregiver and patient mood (Miller et al, 1996). Secondly, when patients and caregivers 
discussed change under similar themes, their motives were sometimes different. This 
was most apparent in relation to discussions around independence/freedom, in which 
some caregivers hoped increased patient independence would increase their own 
independence. Caregiving in PD impairs carers‟ social functioning (Schrag et al, 2006), 
and their desire for increased independence may reflect this. 
 
A number of participants had uncertain expectations of STN-DBS, yet were willing to 
proceed with surgery partly due to confidence in the treating clinician. This perhaps 
resonates with Williams‟ (1994) observation that “the greater the perceived esoteric or 
technical nature of treatment the more likely it is that many service users will not 
believe in the legitimacy of holding their own expectations” (p.513). Some patients also 
formed their expectations on hearing other patients‟ outcomes. Thompson & Suñol 
(1995) refer to these as „normative expectations‟, suggesting what „ought to happen‟ 
based on others‟ accounts. Interestingly patients spoke of others who had experienced 
very positive outcomes. Yet Folkes (1990) postulates that satisfaction is greater when 
people perceive their outcome as more favourable than that of others. By this rationale, 
expectations based on others‟ positive outcomes may be unhelpful. 
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All participants believed problems would remain after surgery, but they would be more 
manageable. Many commented that they had not really considered what issues would 
remain. Participants expected their subsequent evaluations of STN-DBS would be 
influenced by the extent of motor symptom improvement. Many felt STN-DBS could 
have a substantial impact on symptoms, yet believed even a small improvement would 
be evaluated positively. Many described setting objective markers to evaluate 
improvement, whilst others described a more subjective experience of “I‟ll just know”. 
Complications of surgery, in particular perioperative complications, were factors 
expected to result in dissatisfaction. 
 
Satisfaction with STN-DBS 
 
Participants evaluated STN-DBS based on reductions in motor symptoms and 
medication, largely consistent with those symptoms discussed pre-surgery. Patients and 
caregivers did not differ in the symptoms discussed. Dissatisfaction occurred when 
symptoms did not improve or deteriorated. The possibility of symptoms becoming 
worse had not been anticipated. A number of participants found improvements in some 
symptoms were accompanied by deterioration in others, with evaluations of STN-DBS 
based on the wider implications of this new symptom profile. All spoke of fluctuations 
in symptom change, with corresponding fluctuations in their satisfaction. For some, 
whilst STN-DBS had improved symptoms from pre-surgical levels, if this represented 
an attenuated effect on their immediate post-surgical improvement then there was some 
dissatisfaction. Dissatisfaction also arose if participants felt the pace of improvement 
had been slow. These factors had not been identified as issues expected to impact on 
satisfaction. 
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All evaluated STN-DBS‟s impact on „quality of life‟, largely overlapping with pre-
surgical expectations. However, participants no longer discussed hobbies or 
employment opportunities. It is unclear why these themes were no longer discussed, 
although many talked of improvements in „general functional ability‟ which may have 
incorporated hobbies. Patients and caregivers again showed some subtle differences in 
discussion around „quality of life‟. The only notable change from pre-surgical 
discussion was that patients now discussed the impact of STN-DBS on their emotional 
well-being. Interestingly this only occurred when patients felt surgery had impacted 
negatively on their mood. Deterioration in mood following STN-DBS has been found in 
a minority of patients (Berney et al, 2002). 
 
Participants evaluated surgery based on unexpected implications of the stimulator. 
Patients noted the stimulator apparatus resulted in physical discomfort and body image 
concerns. Other studies have found these issues are raised by patients following STN-
DBS (Schüpbach et al, 2006). Both patients and caregivers also noted side effects of 
stimulation. This included deterioration in motor symptoms, but also non-motor 
problems such as “weepiness” without accompanying negative affect (i.e. pseudobulbar 
crying), dysarthria, mental slowness and mood disturbance. These side effects have 
been reported elsewhere (Berney et al, 2002; Limousin & Martinez-Torres, 2008; Okun 
et al, 2004; Temel et al, 2006). Whilst prior to surgery participants identified surgical 
complications as likely to result in dissatisfaction, this typically corresponded to 
perioperative trauma rather than effects related to neuronal stimulation. 
 
Participants also based satisfaction around how medical interventions were delivered, 
congruent with Parasuraman et al‟s (1991) proposal that satisfaction is based not only 
on outcome, but also process issues around service delivery. Patients spoke of 
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satisfaction based on the timeliness and comfort of the surgical procedure. Both patients 
and caregivers described dissatisfaction around the process of stimulator adjustment; 
often from feelings of confusion around how such adjustments were undertaken. The 
inconvenience of attending numerous hospital appointments for stimulator adjustments 
was also noted. Finally, participants spoke of the important role of the medical team 
when evaluating surgery. Increased satisfaction occurred when staff were supportive 
and available to carers, provided information and prepared the caregiver for the post-
operative recovery period, and where they were inclusive of caregivers in a 
collaborative approach to patient care. None of the above issues were raised by 
participants in their pre-surgical discussion of how they expected surgery would be 
evaluated. 
 
Clinical Implications: 
 
Ensuring informed consent: 
Siddiqui et al (2008) stress that in STN-DBS “the importance of instilling realistic 
patient expectations before surgery cannot be overemphasised” (p.85). Indeed, 
clinicians have a duty of care to ensure patients provide informed consent prior to 
treatment (Department of Health, 2001). This study suggests patients and caregivers 
require more guidance around considering the possibility that motor symptoms may 
deteriorate or new symptoms appear post-surgery. Participants‟ discussions of 
complications focused on perioperative complications rather than side effects from 
neuronal stimulation; yet the latter are far more common (Hariz, 2002). Interestingly all 
patients undergoing surgery at the movement disorder clinics in this study are provided 
with an information leaflet outlining these risks. Therefore services may wish to 
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evaluate how the provision of this information is undertaken so that patients are more 
alert to such risks and their potential impact on satisfaction.  
 
Improving satisfaction with evolving post-surgical change 
The post-operative recovery period is recognised as a demanding time for patients 
(Okun et al, 2007). Participants identified fluctuating motor symptom improvements 
and the stimulator adjustment process as significant factors impacting on satisfaction. 
Interestingly participants‟ accounts suggest that satisfaction could be improved through 
the actions of medical staff. Dissatisfaction was more likely when participants felt 
„confused‟ regarding how stimulator adjustments were conducted. Ensuring care-
recipients are kept informed regarding the rationale behind such interventions, and 
allowing them to contribute to this process, may increase satisfaction. Indeed, this study 
found that when the medical team encouraged collaboration this was positively 
received. It may also be helpful for services to consider the demands repeated hospital 
visits places on caregivers, and where necessary be flexible regarding appointments or 
help facilitate the patient‟s attendance without the involvement of caregivers. 
 
Considering the formation of expectations 
This study found that many patients form their expectations of surgery through hearing 
stories of other surgical candidates that have received STN-DBS. In all cases, these 
stories described very positive outcomes, which are unlikely to be fully representative 
of all surgical patients. High „normative expectations‟ are more likely to result in 
dissatisfaction (Boulding et al, 1993) and staff need to be aware of such influences and 
ensure that patients understand that such outcomes, whilst possible, are not typical. This 
may be facilitated through providing patients with the opportunity to speak to previous 
STN-DBS patients whom staff feel have had a more typical outcome. 
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Furthermore, a number of participants who felt uncertain about likely surgical outcomes 
described placing their faith in the treating clinician. Yet, the danger is that should the 
outcome not match the patient‟s unspoken expectations then frustration may be directed 
towards staff, which could in turn impact on compliance with post-operative medical 
management. As Ross et al (1987) highlight, “In the long term, „faith in the physician‟ 
may be a poor substitute for informed consumption of services” (p. 24). Surgical 
candidates should therefore be encouraged to make explicit their hopes around STN-
DBS and accept ownership of such expectations. 
 
Strengths and Limitations of this Research 
 
The main strength of this research is that it represents the first study to provide a voice 
to those patients and caregivers undergoing STN-DBS. Encouraging service-user 
evaluations of NHS services is increasingly seen as essential for service development 
(Department of Health, 2004). Furthermore, since a number of aspects of this study‟s 
methodology were developed alongside service-user input, it increases the likelihood 
that the findings represent areas of importance for this patient group. Finally, the use of 
a qualitative design was not only appropriate for the research question, but also adds to 
the expanding literature using qualitative methodologies in examining patients‟ 
experiences of neurosurgical services (Knifed et al, 2008; Palese et al, 2008). 
 
However, it is important to recognise that results may be influenced by the context of 
the study and characteristics of the researcher and sample. Given the researcher‟s 
clinical experience of evaluating STN-DBS from a medical perspective, this may have 
biased the interpretation of data towards a more symptom-based analysis. Whilst 
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employing a second coder aimed to reduce such biases, this would not impact on data 
collection. Furthermore, participants may have associated the researcher with the 
healthcare team, priming them to frame their responses around medical issues. Given 
that staff facilitated participants‟ recruitment into the study, this is a possibility. 
 
It is also important to consider the composition of the sample. The majority of patients 
were male and caregivers tended to be female. Most participants were elderly. Whilst 
these sociodemographics are broadly representative of the wider PD population (Van 
den Eeden et al, 2003), the extent to which this study‟s findings are applicable to care-
recipients of differing sociodemographics is uncertain. Furthermore, the context in 
which participants were recruited may have impacted on the generalisability of results. 
Both hospital sites conduct comprehensive examinations of patients‟ suitability for 
surgery, including examining the appropriateness of their expectations. This may 
explain why participants voiced „realistic‟ expectations in relation to change in motor 
symptoms and quality of life. Whether similar results would have been obtained from 
participants at hospitals adopting a less rigorous pre-surgical evaluation remains 
unknown. 
 
A further limitation in the study was the inconsistent follow-up period for participants. 
Delays in participant recruitment meant that a number of post-surgery interviews had to 
be conducted prior to the desired 6 month mark, limiting the amount of time these 
participants had to evaluate change. However, it is noteworthy that the majority of PD 
service-users who provided input into the study‟s design felt that a 3 month follow-up 
would be appropriate.  
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A final limitation is that respondent validation was not undertaken. Whilst TA rejects 
the use of validity assessments, it accepts that respondent “feedback” can aid the 
researcher‟s consideration of alternative data interpretations. Practical constraints, 
primarily participants‟ infrequent and time pressured hospital visits, meant this 
approach was not feasible. The employment of two independent coders was felt an 
appropriate alternative. 
 
Directions for Future Research 
  
A number of areas require further research. Firstly, it is important to investigate whether 
these results are found in other PD patient and caregiver samples due to undergo STN-
DBS. Qualitative methodologies accept the generalisability of results may be 
questionable since they are seen to be influenced by such things as contextual factors 
and researcher biases in data analysis. Should similar findings be uncovered by other 
researchers in other contexts then this increases the credibility of claims that these 
findings are more widely applicable. 
 
Secondly, this qualitative study provides an essential grounding for further quantitative 
research into satisfaction with STN-DBS. In particular, examination of the relative 
predictive power of themes outlined in this study in determining satisfaction would be 
beneficial. 
 
Thirdly, research is needed into how services can improve rates of care-recipient 
satisfaction with STN-DBS. One approach could be to develop and evaluate a pre-
surgical educational intervention designed to ensure surgical candidates have realistic 
expectations of surgical outcome, particularly in relation to the possibility of new 
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symptoms. Another could be to examine whether satisfaction with STN-DBS can be 
improved through adapting post-operative medical procedures (e.g. stimulator 
adjustment) so that care-recipients have a greater sense of understanding and control in 
relation to how these are undertaken.  
 
Conclusions 
 
Deep brain stimulation is an effective intervention for motor symptom reduction in PD 
and remains one of the few treatments available to patients whose symptoms can no 
longer be managed by medication. Yet prior to this study, there had been limited 
examination of how care-recipients appraise this treatment. The current findings suggest 
that care-recipients expect satisfaction with STN-DBS to arise following improvements 
in motor symptoms and quality of life, when perioperative side effects are absent. In 
reality post-surgical outcomes are more complex. Many care-recipients find themselves 
evaluating a post-surgical outcome which includes improvements in some areas, but 
with contrasting deterioration in other aspects of their symptom profile. Furthermore, 
desired change is not instant and care-recipients often face a prolonged and uncertain 
post-operative recovery period involving fluctuations in symptom improvement. 
Services which provide STN-DBS need to ensure that surgical candidates are aware of 
the complexity of possible outcomes and work collaboratively with care-recipients 
during the post-surgical adjustment period to facilitate increased satisfaction.  
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Author Guidelines 
 
Scope 
Movement Disorders publishes Full-length Articles, Reviews, Viewpoints, Brief 
Reports, and Letters. Case reports in which interesting diagnostic difficulties arose in 
which a definitive pathological or genetic diagnosis was ultimately made can be 
submitted for the Clinico-Pathological Grand Round section of the journal. The case 
history and the pathological findings should be submitted to the editors. If the editor 
determines that the report is appropriate for the Grand Round format two referees can be 
solicited to discuss the case and become co-authors of the report. All articles in 
Movement Disorders, including letters, can be accompanied by a video when 
appropriate. 
Authors for whom English is a second language may choose to have their manuscript 
professionally edited before submission to improve the English. A list of independent 
suppliers of editing services can be found at 
www.blackwellpublishing.com/bauthor/english_language.asp. Japanese authors can 
also find a list of local English improvement services at 
http://www.wiley.co.jp/journals/editcontribute.html. All services are paid for and 
arranged by the author, and use of one of these services does not guarantee acceptance 
or preference for publication. 
 Full-Length Articles: Full-length articles present new data in any field related 
to movement disorders. Suggested length: Abstract up to 250 words, text up to 
2700 words, and up to 5 tables and/or figures, legends. The word count must 
appear on the title page. 
 Reviews and Viewpoints: Clinical and basic science Reviews or Viewpoints 
that provide a position statement or summary are generally published upon 
request or after agreement with the editors of Movement Disorders. Authors 
interested in writing Reviews or Viewpoints may contact the respective Editor-
in-Chief, and unsolicited Reviews and Viewpoints will also be considered for 
publication. Suggested length will be individually discussed. 
 Brief Reports: Brief reports are short reports, original studies, or 
evaluations.Suggested length: Abstract up to 150 words, text up to 1500 words, 
and up to 2 tables, and/or figures, legends. The word count must appear on the 
title page. This section may also include video-based reports of interesting cases 
or educational observations with a very brief clinical description. In addition, 
patient photographs or samples of imaging studies demonstrating a unique 
observation or educational point accompanied by a very brief commentary 
legend can be submitted. 
 Letters: Letters to the Editor allow publication related to previously published 
material in the Journal or interesting new observations. This section is also the 
appropriate venue for brief reports or case histories with or without videos. A 
letter related to published materials may be submitted up to 12 weeks after the 
paper to which it refers was published in print. Text length can be up to 500 
words with up to 5 references for letters related to published articles, up to 250 
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words and up to 5 references for letters related to published letters, and up to 
700 words with up to 7 references for new cases. Letters may have up to 1 table 
and/or figure with legends. No abstract is needed but a title page is required. 
 Clinical Trial Reports: Clinical Trial Reports must be written in accordance 
with the Consolidated Standards of Reporting Trials (CONSORT) statement 
(Moher D et al., JAMA 2001;285:1987–1991; see also Moher D et al., Lancet 
2001;357:1191–1194). Authors should ensure that information on all of the 
critical design features listed in the CONSORT checklist is reported in the 
manuscript. (Reviewers are provided with the checklist to assess the manuscript 
for the relevant content). The CONSORT flow diagram (figure) should be 
included with the manuscript, clearly outlining the flow of patients through the 
trial. In addition, a statement is required in the cover letter specifically 
confirming that there has been no ghost writing by anyone not named on the 
author list (see Editorial in Movement Disorders 2005;20:1536). The precise 
financial relationship between a clinical trial sponsor and the authors must be 
delineated in the manuscript. 
Form of Manuscripts. 
The text of the manuscript should be in the following sequence: (1) Title page, (2) 
Abstract, (3) Introduction, (4) Methods, (5) Results, (6) Discussion, (7) 
Acknowledgment, (8) Authors' Roles, (9) Financial Disclosures of all authors (for the 
preceding 12 months), (10) References, (11) Video Legend, (12) Figures, and (13) 
Tables. Pages should be numbered in succession, the title page being one. 
Title: Titles should be short, specific, and clear. They should not exceed 100 characters. 
Do not use abbreviations in the title. 
Title Page:The opening page of each manuscript should include only: (1) article title; 
(2) authors' names and affiliations (indicate the specific affiliation of each author by 
superscript, Arabic numerals); (3) name, address, and telephone and fax numbers of the 
person to whom proofs should be addressed; (4) word count; (5) any necessary 
footnotes to these items; (6) a running title not exceeding 45 letters and spaces; (7) Key 
words; (8) Financial Disclosure/Conflict of Interest concerning the research related to 
the manuscript: All information on support and financial issues from all authors relative 
to the research covered in the submitted manuscript must be disclosed regardless of 
date. Other financial information unrelated to the current research covering the past year 
will be documented at the end of the manuscript (see below). Note that submissions 
without this Financial Disclosure on the Title Page will be returned to the author. For 
clinical trials, a statement on ghost-writing is required (Movement Disorders 
2005;20:1536). 
Abstract:The page following the title page of Full-Length Articles should include a 
brief abstract of up to 250 words describing the background, methods, results, and 
conclusions of the study. We encourage authors to submit papers with structured 
abstracts, especially for clinical trial papers. The page following the title page of a Brief 
Report should include a brief abstract of up to 100 words. 
Key words: Up to six key words or terms should be provided following the abstract. 
Introduction: Give a brief description of the background of the scientific contribution. 
Methods:Informed consent: For experimental investigation of human or animal 
subjects, please state in this section that an appropriate institutional review board 
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approved the project. For those investigators who do not have formal ethics review 
committees, the principles outlined in the “Declaration of Helsinki” should be followed. 
For investigations in human subjects, state in this section the manner in which informed 
consent was obtained from the subjects. A letter of consent must accompany all 
photographs, patient descriptions, and pedigrees in which a possibility of identification 
exists. The authors are responsible for proper anonymisation of their patients. 
Results: No specific regulations. 
Discussion: No specific regulations. 
Acknowledgment: No specific regulations. 
Author Roles: List all authors along with their specific roles in the project and 
preparation of the manuscript. These may include but are not restricted to: 1) Research 
project: A. Conception, B. Organization, C. Execution; 2) Statistical Analysis: A. 
Design, B. Execution, C. Review and Critique; 3) Manuscript: A. Writing of the first 
draft, B. Review and Critique. 
Full Financial Disclosures of all Authors for the Past Year: Information concerning 
all sources of financial support and funding for the preceding twelve months, regardless 
of relationship to current manuscript must be submitted with the following categories 
suggested. List sources or “none”. 
  
Stock Ownership in medically-related fields Intellectual Property Rights 
Consultancies Expert Testimony 
Advisory Boards Employment 
Partnerships Contracts 
Honoraria Royalties 
Grants Other 
  
References: See “Details of Style” for the proper formatting of citations and 
References. 
Video Legend: No specific regulations. 
Tables and Figure Legends: Double-space legends of fewer than 40 words for tables 
and figures. For photomicrographs, include the type of specimen, original 
magnification, and stain type. Include internal scale-markers on photomicrographs. 
Where applicable, indicate the method used to digitally enhance images. 
Tables: Tables should be typed neatly, each on a separate page, with a title above and 
any notes below. Explain all abbreviations. Do not repeat the same information in tables 
and figures or tables and text. 
Figures and Illustrations: Adapt any figures to an appropriate size of art and letters to 
make them readable in the printed version. Illustrations in full color are accepted at 
additional charge from the publisher. Any illustration or figure from another publication 
must be acknowledged in the figure legend, and the copyright holder‟s written 
permission to reprint in print and online edition of Movement Disorders must be 
submitted to the editors. 
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Copyright and Disclosure Forms The corresponding author should upload one PDF 
file that includes copyright and disclosure forms for all authors to the Movement 
Disorders submission site with the revised version of the paper. These forms also can be 
emailed to mdjedoffice@movementdisorders.org. 
Digital Artwork Preparation 
For best reproduction, electronic artwork files must be in TIFF or EPS format, at a 
resolution of 600 dpi or higher, sized to print. Movement Disorders offers Rapid 
Inspector™ to help ensure that your electronic graphics files are suitable for print 
purposes. This free, stand-alone software application will help you to inspect and verify 
illustrations right on your computer. Go to 
http://rapidinspector.cadmus.com/wi/index.jsp and create a new account. 
Details of Style 
No patient identifiers (e.g., patient initials) are to be included in the manuscript or video 
(e.g., case reports, tables, figures, etc.). 
Units of measure: Conventional units of measure according to the Systeme 
International (SI) are preferred. The metric system is preferred for length, area, mass, 
and volume. Express temperature in degrees Celsius. 
Drug Names: Use generic names only in referring to drugs, followed in parentheses 
after first mention by any commonly used generic variant. 
Abbreviations: Follow the list of abbreviations given in "Uniform Requirements for 
Manuscripts Submitted to Biomedical Journals" (see section on References). For 
additional abbreviations, consult the CBE Style Manual (available from the Council of 
Biology Editors, 9650 Rockville Pike, Bethesda, Maryland 20814, USA) or other 
standard sources. 
Spelling: American spelling is used throughout the Journal. 
References 
Movement Disorders complies with the reference style given in "Uniform Requirements 
for Manuscripts Submitted to Biomedical Journals". (See Annals of Internal Medicine 
1982;96:766-771, or British Medical Journal 1982:284:1766-1770.) 
References are to be cited in the text by number, and in the list of References they are to 
be numbered in the order in which they are cited. The reference section should be 
double-spaced at the end of the text, following the sample formats given below. Provide 
all authors' names when fewer than seven; when seven or more, list the first three and 
add et al. Provide article titles and inclusive pages. Accuracy of reference data is the 
responsibility of the author. For abbreviations of journal names, refer to List of Journals 
Indexed in Index Medicus (available from the Superintendent of Documents, U.S. 
Government Printing Office, Washington DC 20402, USA, DHEW Publication No. 
(NIH) 83-267; ISSN 0093-3821). 
Sample References 
·        Journal article: 
1. Horgan JH, O'Callaghan WG, Teo KK. Therapy of angina pectoris with low-dose 
perhexiline. J Cardiovasc Pharmacol 1981;3:566–572. 
126 
 
·        Book: 
2. Vanhoutte PM, Leusen I, editors. Vasodilatation. New York: Raven Press; 1981. 
96 p. 
·        Chapter in a book: 
3. Patrono C, Ciabattoni G, Pugliese F, et al. Effect of dietary variation in linoleic 
acid content on platelet aggregation and the major urinary metabolites of the E 
prostaglandins and (PGE-M) in infants. In: Hegyeli RJ, editor. Prostaglandins and 
cardiovascular disease. New York: Raven Press; 1981. p 111–122. (Atherosclerosis 
reviews; vol. 8). 
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Appendix 3 
Literature search tables 
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Included below are the results of literature searches conducted using the key words as 
stated in the Search Strategy section of the Literature Review. 
 
The following comes from a combined search of PsycINFO, OVID Medline, the and 
British Nursing Index: 
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The table below shows the search results from the Cumulative Index to Nursing and 
Allied Health Literature (CINAHL): 
 
 
 
The last table shows the search results from Web of Science: 
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Zarit Burden Inventory 
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Worked Example of Template Analysis 
 
This section provides an example of how transcript examination was undertaken with 
Template Analysis. The focus will be patients‟ pre-surgical interviews. This first step 
involved identifying sections of text concerned with surgical expectations. Codes were 
placed in the right hand column summarising and interpreting the meaning of such text. 
 
The example below is a short extract from Paul‟s interview. 
 
 
Transcript Open Coding 
I 
 
 
 
 
 
P 
And then I guess that kind of brings us up to 
surgery. What are your thoughts now when you 
think about surgery – deep brain stimulation? 
 
Well really having been almost volunteered by 
someone who was pretty knowledgeable about 
it, I never really thought too deeply about it. 
Again, I‟ve never looked at the downsides, I‟ve 
always tried to be very positive. I looked at 
certain case histories and by then I‟d started 
taking up golf and was playing green bowls as 
well and, um, realised that was becoming more 
difficult. And then I read about this guy who 
was a professional golfer in the States who‟d 
had Deep Brain and went back and became 
again a professional golfer, so I thought „well 
that can‟t be too bad if you can achieve that kind 
of success then there might be something really 
worthwhile here‟. I never really had the 
expectations of becoming a professional golfer 
(LAUGHTER) as a result of deep brain 
stimulation. I just wanted relief from the 
discomfort of the tremor, because I was then on 
my maximum medication. But the chance to 
reduce that would be good. 
 
 
 
 
 
 
Reliant on opinion of physician 
Confidence in treating clinician 
Limited consideration of 
outcome 
Acceptance of downsides 
Limited consideration of 
downsides 
Optimism 
Expectations based on hearing 
about others 
 
 
 
Expectations based on hearing 
about others 
 
Improvements in hobbies 
 
 
 
 
Possibility of good outcome 
 
 
 
 
 
Improvement in tremor 
 
 
Reduced medication 
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The next stage involved examining whether codes could be grouped into higher-order 
themes. The a priori assumptions of the study were that themes around change in motor 
symptoms and quality of life would be discussed. Where these themes did not 
accurately describe codes, alternative themes were proposed:  
 
 
 
First Order Theme 
 
Second Order Theme 
 
Codes 
 
CHANGE FOLLOWING 
SURGERY 
MOTOR SYMPTOMS 
AND/OR  
MEDICATION 
Improvement in tremor 
Reduced medication 
 
 
 QUALITY OF LIFE Improved hobbies 
 
 
 
 UNCERTAINTY 
AROUND CHANGE 
Reliant on opinion of 
clinician 
Confidence in opinion of 
treating clinician 
 
 
 HEARING ABOUT 
OTHERS 
 
Expectations based on 
others‟ case histories 
Expectations base on media 
stories 
Possibility of a good 
outcome from stories 
 
 
PROBLEMS THAT 
COULD REMAIN / NEW 
PROBLEMS 
 
 
NOT A CURE 
 
Acceptance of downsides 
 LIMITED 
CONSIDERATION OF 
DOWNSIDES 
Limited consideration of 
downsides 
Optimism 
 
 
 
Whilst in practice the initial template was more detailed due to being developed on a 
larger transcript, for the sake of this worked example the themes outlined above shall be 
considered the initial template.  
 
The next stage involved applying the template to the next participant interview to 
examine whether it accurately summarised the themes that emerged. Overleaf is an 
extract from Alex‟s interview. The initial template will be applied in the right-hand 
column. Where the template does not accurately describe emergent themes, a question 
mark is put in place. 
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Transcript First 
order 
themes 
Secondary 
themes 
Codes 
I 
 
 
 
P 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
I 
 
 
 
P 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
So what is your understanding of what 
surgery can offer? 
 
The main thing for me is dropping my meds 
down, they say it will cut them by at least a 
half which will be the main benefit for me I 
think. That should get rid of my involuntary 
movements. I‟ve been falling lately, over 
the last few months and that‟s another 
reason why I went for the surgery but I 
understand it‟s not going to be effective for 
that, but that‟s alright, I can cope with that 
if the rest is better. 
 
So can you tell me why those things are 
important for you? 
 
I mean I‟m quite into sport so, I used to 
play badminton and go cycling a lot and go 
walking, skiing.  I will be able to do all 
those things better than I can now.  I mean I 
still do most of them, but just like walking, 
I can't do, well I can do I suppose but it 
would knacker me out to do a ten mile walk 
so we tend to do two or three miles now. 
Yeah, just play more sport and socialise 
more I think. I think I‟m fine with 
socialising with my friends but if I am 
meeting new people I find that quite 
difficult because I think they will be 
wondering what is wrong with me. 
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Reduced 
medication 
 
 
Reduced 
dyskinesia 
 
 
 
Falling will 
remain 
 
 
Falling will 
be 
manageable 
 
 
 
 
 
 
 
 
Be better at 
sports 
 
 
 
More 
energy for 
sports 
 
 
 
Socialise 
more 
 
Less 
discomfort 
around 
strangers 
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Applying the template to Alex‟s script revealed some overlap in the themes discussed in 
Paul‟s interview. However, there were also some areas of the transcript that the initial 
template was not able to summarise. The initial template from Paul‟s interview is 
presented below. Modifications made to the template based on Alex‟s interview are 
shown in italics. 
 
 
First Order Theme Second Order Theme Codes 
 
CHANGE FOLLOWING 
SURGERY 
MOTOR SYMPTOMS 
AND/OR  
MEDICATION 
Improvement in tremor 
Reduced medication 
Reduced medication 
Improved dyskinesia 
 
 
 QUALITY OF LIFE 
 
 
 
 
 
 
 
 
 H
o
b
b
ie
s Improved hobbies 
Being better at hobbies 
More energy for sports 
 
S
o
ci
a
li
si
n
g
 Socialise more 
Less discomfort around 
strangers 
 UNCERTAINTY 
AROUND CHANGE 
Reliant on opinion of 
clinician 
Confidence in opinion of 
treating clinician 
 
 
 HEARING ABOUT 
OTHERS 
 
Expectations based on 
others‟ case histories 
Expectations base on 
media stories 
Possibility of a good 
outcome from stories 
 
 
PROBLEMS THAT 
COULD REMAIN / 
NEW PROBLEMS 
 
 
NOT A CURE 
 
Acceptance of downsides 
Falling will remain 
 LIMITED 
CONSIDERATION OF 
DOWNSIDES 
Limited consideration of 
downsides 
Optimism 
 
 
 
 
 
REMAINING PROBLEMS 
NOT SO BAD 
Falling will be more 
manageable 
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As can be seen, the analysis of Paul‟s transcript:  
 
 Added to some already formed themes (e.g. dyskinesia was added to the „motor 
symptom‟ theme) 
 Resulted in the modification of themes (e.g. the „quality of life‟ theme was split 
into changes in „hobbies‟ and „socialising‟) 
 Necessitated the formation of new themes (e.g. „Remaining problems not as bad‟ 
theme). 
 
This modified template was then re-applied to Paul‟s transcript to ensure that it 
continued to accurately summarise his transcript. Following this, the modified template 
was then applied to the next participant‟s transcript. This process of modifying the 
template based on considerations emerging from successive interviews continued until a 
final template was produced which accurately summarised all codes deemed relevant to 
the research question across all transcripts. 
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